# EDGAR Filing Document

**Accession Number:** 0001352010
**File Stem:** 0001352010-25-000056
**Filing Date:** 2025-11
**Character Count:** 206525
**Document Hash:** 2248fcae0a1ad480e279b7813a84a710
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001352010-25-000056.hdr.sgml**: 20251106

**ACCESSION NUMBER**: 0001352010-25-000056

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 96

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251106

**DATE AS OF CHANGE**: 20251106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EPAM Systems, Inc.
- **CENTRAL INDEX KEY:** 0001352010
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 223536104
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35418
- **FILM NUMBER:** 251458391

**BUSINESS ADDRESS:**
- **STREET 1:** 41 UNIVERSITY DRIVE
- **STREET 2:** SUITE 202
- **CITY:** NEWTOWN
- **STATE:** PA
- **ZIP:** 18940
- **BUSINESS PHONE:** (267) 759-9000

**MAIL ADDRESS:**
- **STREET 1:** 41 UNIVERSITY DRIVE
- **STREET 2:** SUITE 202
- **CITY:** NEWTOWN
- **STATE:** PA
- **ZIP:** 18940

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EPAM SYSTEMS INC
- **DATE OF NAME CHANGE:** 20060202

?xml version='1.0' encoding='ASCII'? epam-20250930

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ________to________**

**Commission file number: 001-35418**![Logo_New.gif](epam-20250930_g1.gif)

**EPAM SYSTEMS, INC.** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **Delaware** | **22-3536104** |
| (State or other jurisdiction of<br>incorporation or organization) | (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |
| **41 University Drive** | **Suite 202** | **18940** |
| **Newtown** | **Pennsylvania** | **18940** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Address of principal executive offices) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Address of principal executive offices) | (Zip code) |

---

**267-759-9000** 

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of Each Class</u>** | **<u>Trading Symbol</u>** | **<u>Name of Each Exchange on which Registered</u>** |
| **Common Stock, par value $0.001 per share** | **EPAM** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

---

| | |
|:---|:---|
| **<u>Title of Each Class</u>** | **<u>Outstanding as of October 31, 2025</u>** |
| **Common Stock, par value $0.001 per share** | **55,242,618 shares** |

---

------

**EPAM SYSTEMS, INC.**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| | **Page** |
| **<u>[PART I. FINANCIAL INFORMATION](#i77da24089f294b0e9bff2a6a11637bd1_10)</u>** | <u>[3](#i77da24089f294b0e9bff2a6a11637bd1_10)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1. Financial Statements (Unaudited)](#i77da24089f294b0e9bff2a6a11637bd1_13)</u> | <u>[3](#i77da24089f294b0e9bff2a6a11637bd1_13)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*<u>[Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024](#i77da24089f294b0e9bff2a6a11637bd1_16)</u>* | <u>[3](#i77da24089f294b0e9bff2a6a11637bd1_16)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*<u>[Condensed Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2025 and 2024](#i77da24089f294b0e9bff2a6a11637bd1_19)</u>* | <u>[4](#i77da24089f294b0e9bff2a6a11637bd1_19)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*<u>[Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2025 and 2024](#i77da24089f294b0e9bff2a6a11637bd1_22)</u>* | <u>[5](#i77da24089f294b0e9bff2a6a11637bd1_22)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*<u>[Condensed Consolidated Statements of Changes in Equity for the Three and Nine Months Ended September 30, 2025 and 2024](#i77da24089f294b0e9bff2a6a11637bd1_25)</u>* | <u>[6](#i77da24089f294b0e9bff2a6a11637bd1_25)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*<u>[Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024](#i77da24089f294b0e9bff2a6a11637bd1_28)</u>* | <u>[8](#i77da24089f294b0e9bff2a6a11637bd1_28)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*<u>[Notes to Condensed Consolidated Financial Statements](#i77da24089f294b0e9bff2a6a11637bd1_31)</u>* | <u>[10](#i77da24089f294b0e9bff2a6a11637bd1_31)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#i77da24089f294b0e9bff2a6a11637bd1_91)</u> | <u>[34](#i77da24089f294b0e9bff2a6a11637bd1_91)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#i77da24089f294b0e9bff2a6a11637bd1_160)</u> | <u>[45](#i77da24089f294b0e9bff2a6a11637bd1_160)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 4. Controls and Procedures](#i77da24089f294b0e9bff2a6a11637bd1_172)</u> | <u>[47](#i77da24089f294b0e9bff2a6a11637bd1_172)</u> |
| **<u>[PART II. OTHER INFORMATION](#i77da24089f294b0e9bff2a6a11637bd1_175)</u>** | <u>[47](#i77da24089f294b0e9bff2a6a11637bd1_175)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1. Legal Proceedings](#i77da24089f294b0e9bff2a6a11637bd1_178)</u> | <u>[47](#i77da24089f294b0e9bff2a6a11637bd1_178)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1A. Risk Factors](#i77da24089f294b0e9bff2a6a11637bd1_181)</u> | <u>[47](#i77da24089f294b0e9bff2a6a11637bd1_181)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#i77da24089f294b0e9bff2a6a11637bd1_184)</u> | <u>[47](#i77da24089f294b0e9bff2a6a11637bd1_184)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 3. Defaults Upon Senior Securities](#i77da24089f294b0e9bff2a6a11637bd1_187)</u> | <u>[48](#i77da24089f294b0e9bff2a6a11637bd1_187)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 4. Mine Safety Disclosures](#i77da24089f294b0e9bff2a6a11637bd1_190)</u> | <u>[48](#i77da24089f294b0e9bff2a6a11637bd1_190)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 5. Other Information](#i77da24089f294b0e9bff2a6a11637bd1_193)</u> | <u>[48](#i77da24089f294b0e9bff2a6a11637bd1_193)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 6. Exhibits](#i77da24089f294b0e9bff2a6a11637bd1_199)</u> | <u>[49](#i77da24089f294b0e9bff2a6a11637bd1_199)</u> |
| **<u>[SIGNATURES](#i77da24089f294b0e9bff2a6a11637bd1_202)</u>** | <u>[50](#i77da24089f294b0e9bff2a6a11637bd1_202)</u> |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**PART I. FINANCIAL INFORMATION**

***Item 1. Financial Statements (Unaudited)***

**EPAM SYSTEMS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(Unaudited)**

**(In thousands, except par value)**

---

| | | |
|:---|:---|:---|
| | **As of <br>September 30,<br>2025** | **As of <br>December 31,<br>2024** |
| **Assets** | | |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $1239136 | $1286267 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade receivables and contract assets, net of allowance of $4,481 and $5,612, respectively | 1130496 | 1002175 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid and other current assets | 154408 | 137806 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 2524040 | 2426248 |
| Property and equipment, net | 198821 | 207667 |
| Operating lease right-of-use assets, net | 123439 | 128244 |
| Intangible assets, net | 419806 | 436418 |
| Goodwill | 1208912 | 1181575 |
| Deferred tax assets | 235318 | 269799 |
| Other noncurrent assets | 132964 | 100522 |
| **Total assets** | $**4843300** | $**4750473** |
| **Liabilities** |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $42981 | $44702 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation and benefits expenses | 543738 | 484952 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 188591 | 201356 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable, current | 19492 | 50395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities, current | 40460 | 39634 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 835262 | 821039 |
| Long-term debt | 25036 | 25194 |
| Operating lease liabilities, noncurrent | 89721 | 98426 |
| Deferred tax liabilities, noncurrent | 96956 | 92362 |
| Other noncurrent liabilities | 69482 | 82301 |
| **Total liabilities** | **1116457** | **1119322** |
| **Commitments and contingencies (Note 15)** |  |  |
| **Equity** |  |  |
| Stockholders' equity |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.001 par value; 160,000 shares authorized; 55,214 shares issued and outstanding at September 30, 2025, and 56,869 shares issued and outstanding at December 31, 2024 | 55 | 57 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 1329512 | 1190222 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 2384297 | 2555796 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income/(loss) | 12397 | (116864) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total EPAM Systems, Inc. stockholders' equity | 3726261 | 3629211 |
| Noncontrolling interest in consolidated subsidiaries | 582 | 1940 |
| **Total equity** | **3726843** | **3631151** |
| **Total liabilities and equity** | $**4843300** | $**4750473** |

---

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**EPAM SYSTEMS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

**(Unaudited)**

**(In thousands, except per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Revenues** | $**1394373** | $**1167527** | $**4049508** | $**3479589** |
| **Operating expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues (exclusive of depreciation and amortization) | 983169 | 763992 | 2899189 | 2409183 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 234948 | 206820 | 685546 | 599331 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 31313 | 19736 | 94024 | 63003 |
| **Income from operations** | **144943** | **176979** | **370749** | **408072** |
| Interest and other income, net | 2302 | 13347 | 11635 | 40425 |
| Foreign exchange loss | (3627) | (710) | (20581) | (1416) |
| **Income before provision for income taxes** | **143618** | **189616** | **361803** | **447081** |
| Provision for income taxes | 36802 | 53270 | 93479 | 95847 |
| **Net income** | $**106816** | $**136346** | $**268324** | $**351234** |
| **Net income per share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.92 | $2.40 | $4.77 | $6.11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $1.91 | $2.37 | $4.75 | $6.04 |
| **Shares used in calculation of net income per share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 55557 | 56910 | 56214 | 57445 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 55817 | 57425 | 56534 | 58166 |

---

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**EPAM SYSTEMS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**(Unaudited)**

**(In thousands)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Net income** | $**106816** | $**136346** | $**268324** | $**351234** |
| Other comprehensive (loss)/income, net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | (925) | 30774 | 111846 | 6413 |
| &nbsp;&nbsp;&nbsp;Unrealized (loss)/gain on hedging instruments | (8127) | (1994) | 16738 | (8334) |
| &nbsp;&nbsp;&nbsp;Defined benefit plans | 135 | 126 | 677 | 444 |
| Other comprehensive (loss)/income | (8917) | 28906 | 129261 | (1477) |
| **Comprehensive income** | $**97899** | $**165252** | $**397585** | $**349757** |

---

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**EPAM SYSTEMS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

**(Unaudited)**

**(In thousands)** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Additional Paid-in Capital** | **Retained Earnings** | **Accumulated Other Comprehensive (Loss)/Income** | **Non-Controlling Interest in Consolidated Subsidiaries** | **Total Equity** |
| | **Shares** | **Amount** | | | | | |
| **Balance, January 1, 2025** | **56869** | $**57** | $**1190222** | $**2555796** | $**(116864)** | $**1940** | $**3631151** |
| Restricted stock units vested | 315 |  |  |  |  |  |  |
| Equity withheld for employee taxes | (117) |  | (21455) |  |  |  | (21455) |
| Stock issued in connection with Other 2021 acquisitions | 2 |  | 375 |  |  |  | 375 |
| Stock-based compensation expense |  |  | 46885 |  |  |  | 46885 |
| Exercise of stock options | 353 |  | 19448 |  |  |  | 19448 |
| Repurchase of common stock, including excise tax | (796) |  |  | (160323) |  |  | (160323) |
| Purchase of subsidiary shares from noncontrolling interest |  |  |  |  |  | (1358) | (1358) |
| Other comprehensive income |  |  |  |  | 55011 |  | 55011 |
| Net income |  |  |  | 73482 |  |  | 73482 |
| **Balance, March 31, 2025** | **56626** | $**57** | $**1235475** | $**2468955** | $**(61853)** | $**582** | $**3643216** |
| Restricted stock units vested | 54 |  |  |  |  |  |  |
| Equity withheld for employee taxes | (16) |  | (2420) |  |  |  | (2420) |
| Stock-based compensation expense |  |  | 37914 |  |  |  | 37914 |
| Exercise of stock options | 12 |  | 891 |  |  |  | 891 |
| Issuance of common stock from employee stock purchase plan | 107 |  | 14207 |  |  |  | 14207 |
| Repurchase of common stock, including excise tax | (1087) | (1) |  | (196638) |  |  | (196639) |
| Other comprehensive income |  |  |  |  | 83167 |  | 83167 |
| Net income |  |  |  | 88026 |  |  | 88026 |
| **Balance, June 30, 2025** | **55696** | $**56** | $**1286067** | $**2360343** | $**21314** | $**582** | $**3668362** |
| Restricted stock units vested | 10 |  |  |  |  |  |  |
| Equity withheld for employee taxes | (4) |  | (665) |  |  |  | (665) |
| Stock-based compensation expense |  |  | 43651 |  |  |  | 43651 |
| Exercise of stock options | 5 |  | 459 |  |  |  | 459 |
| Repurchase of common stock, including excise tax | (493) | (1) |  | (82862) |  |  | (82863) |
| Other comprehensive loss |  |  |  |  | (8917) |  | (8917) |
| Net income  |  |  |  | 106816 |  |  | 106816 |
| **Balance, September 30, 2025** | **55214** | $**55** | $**1329512** | $**2384297** | $**12397** | $**582** | $**3726843** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**EPAM SYSTEMS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

**(Unaudited)**

**(In thousands)** 

**(Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Additional Paid-in Capital** | **Retained Earnings** | **Accumulated Other Comprehensive (Loss)/Income** | **Non-Controlling Interest in Consolidated Subsidiaries** | **Total Equity** |
| | **Shares** | **Amount** | | | | | |
| **Balance, January 1, 2024** | **57787** | $**58** | $**1008766** | $**2501107** | $**(39040)** | $**579** | $**3471470** |
| Restricted stock units vested | 261 |  |  |  |  |  |  |
| Equity withheld for employee taxes | (88) |  | (26012) |  |  |  | (26012) |
| Stock-based compensation expense |  |  | 41642 |  |  |  | 41642 |
| Exercise of stock options | 369 |  | 15251 |  |  |  | 15251 |
| Repurchase of common stock | (396) |  |  | (120593) |  |  | (120593) |
| Other comprehensive loss |  |  |  |  | (22312) | (4) | (22316) |
| Net income  |  |  |  | 116243 |  |  | 116243 |
| **Balance, March 31, 2024** | **57933** | $**58** | $**1039647** | $**2496757** | $**(61352)** | $**575** | $**3475685** |
| Restricted stock units vested | 69 |  |  |  |  |  |  |
| Equity withheld for employee taxes | (18) |  | (4577) |  |  |  | (4577) |
| Stock-based compensation expense |  |  | 35285 |  |  |  | 35285 |
| Exercise of stock options | 23 |  | 1339 |  |  |  | 1339 |
| Issuance of common stock from employee stock purchase plan | 85 |  | 15717 |  |  |  | 15717 |
| Repurchase of common stock, including excise tax | (1160) | (1) |  | (216070) |  |  | (216071) |
| Contributions to consolidated subsidiary from noncontrolling interest |  |  |  |  |  | 7 | 7 |
| Other comprehensive loss |  |  |  |  | (8071) |  | (8071) |
| Net income  |  |  |  | 98645 |  |  | 98645 |
| **Balance, June 30, 2024** | **56932** | $**57** | $**1087411** | $**2379332** | $**(69423)** | $**582** | $**3397959** |
| Restricted stock units vested | 7 |  |  |  |  |  |  |
| Equity withheld for employee taxes | (3) |  | (611) |  |  |  | (611) |
| Stock-based compensation expense |  |  | 41136 |  |  |  | 41136 |
| Exercise of stock options | 17 |  | 1302 |  |  |  | 1302 |
| Repurchase of common stock, including excise tax | (245) |  |  | (50409) |  |  | (50409) |
| Other comprehensive income |  |  |  |  | 28906 |  | 28906 |
| Net income  |  |  |  | 136346 |  |  | 136346 |
| **Balance, September 30, 2024** | **56708** | $**57** | $**1129238** | $**2465269** | $**(40517)** | $**582** | $**3554629** |

---

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**EPAM SYSTEMS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

 **(In thousands)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| Net income | $268324 | $351234 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 94024 | 63003 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets amortization expense | 30939 | 28051 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bad debt recovery | (31) | (3071) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred taxes | 3206 | (24888) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 131618 | 122599 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 8359 | 7110 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade receivables and contract assets | (91758) | (22791) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid and other assets | 5382 | (52167) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (5262) | (4611) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | 21862 | 17262 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (32856) | (29604) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | (61763) | (23218) |
| **Net cash provided by operating activities** | **372044** | **428909** |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property and equipment | (27462) | (16419) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of short-term investments | (1966) | (1872) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from short-term investments |  | 41509 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition of business, net of cash acquired (Note 3) | (3344) | (57065) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of non-marketable securities | (720) | (6927) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from non-marketable securities | 2913 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other investing activities, net | (2223) | 1674 |
| **Net cash used in investing activities** | **(32802)** | **(39100)** |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of stock under the employee incentive programs | 35037 | 33781 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments of withholding taxes related to net share settlements of restricted stock units | (24421) | (32465) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of debt | (1842) | (1497) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common stock | (438633) | (385025) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of contingent consideration for previously acquired businesses | (6238) | (4750) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of subsidiary shares from noncontrolling interest | (1358) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other financing activities, net | (1764) | (1711) |
| **Net cash used in financing activities** | **(439219)** | **(391667)** |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 53100 | (543) |
| Net decrease in cash, cash equivalents and restricted cash | (46877) | (2401) |
| Cash, cash equivalents and restricted cash, beginning of period | 1290392 | 2043108 |
| **Cash, cash equivalents and restricted cash, end of period** | $**1243515** | $**2040707** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**EPAM SYSTEMS, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

 **(In thousands)**

**(Continued)**

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets:

---

| | | |
|:---|:---|:---|
| | **As of <br>September 30,<br>2025** | **As of <br>December 31,<br>2024** |
| **Balance sheet classification** | | |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $1239136 | $1286267 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash in Prepaid and other current assets | 418 | 837 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash in Other noncurrent assets | 3961 | 3288 |
| &nbsp;&nbsp;&nbsp;Total restricted cash | 4379 | 4125 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total cash, cash equivalents and restricted cash** | $**1243515** | $**1290392** |

---

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(Unaudited)**

**(In thousands, except per share data and as otherwise disclosed)** 

**1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**&nbsp;&nbsp;&nbsp;&nbsp;

EPAM Systems, Inc. (the "Company" or "EPAM") is a global provider of digital engineering, cloud and AI-enabled transformation services, as well as a leading business and experience consulting partner for global enterprises and ambitious startups. EPAM leverages AI and GenAI to deliver transformative solutions that accelerate its clients' digital innovation and enhance their competitive edge. In a business landscape that is constantly challenged by the pressures of digitization, EPAM focuses on building long-term partnerships with clients in various industries through innovative and scalable software solutions, integrated strategy, experience and technology consulting, and a continually evolving mix of advanced capabilities. The Company is incorporated in Delaware with headquarters in Newtown, Pennsylvania.

**Basis of Presentation** — The accompanying unaudited condensed consolidated financial statements of EPAM have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP" or "U.S. GAAP") and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended. The unaudited condensed consolidated financial statements include the financial statements of EPAM Systems, Inc. and its subsidiaries with all intercompany balances and transactions eliminated.

These unaudited condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's audited consolidated financial statements and the notes thereto for the year ended December 31, 2024 included in its Annual Report on Form 10-K. The preparation of these condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates, and such differences may be material to the unaudited condensed consolidated financial statements. Operating results for the interim periods are not necessarily indicative of results that may be expected to occur for the entire year. In management's opinion, the accompanying unaudited condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair presentation of the Company's financial position as of September 30, 2025 and the results of its operations and its cash flows for the periods presented.

**Risks and Uncertainties** — As a result of its global operations, the Company may be subject to certain inherent risks.

*Concentration of Credit* — Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, short-term investments and trade receivables. The Company maintains cash, cash equivalents and short-term investments with financial institutions. The Company believes its credit policies reflect normal industry terms and business risk and there is no expectation of non-performance by the counterparties.

The Company has cash in several countries, including Ukraine and Belarus, where the banking sector remains subject to periodic instability; banking and other financial systems generally do not meet the banking standards of more developed markets; and bank deposits made by corporate entities are not insured. The Company regularly monitors cash held in these countries and, to the extent the cash held exceeds the amounts required to support its operations in these countries, the Company distributes the excess funds into markets with more developed banking sectors to the extent it is possible to do so. As of September 30, 2025, the Company had $44.7 million of cash and cash equivalents in banks in Ukraine and $24.6 million of cash and cash equivalents in banks in Belarus. In April 2024, Belarus instituted restrictions on distributing dividends from Belarus to shareholders in certain countries, including the U.S. The restrictions are scheduled to remain in place until the end of 2026 and may prevent EPAM from distributing excess funds, if any, out of Belarus. The Company does not expect these restrictions to have a material impact on its ability to meet its worldwide cash obligations during this period. The Company places its cash and cash equivalents with financial institutions considered stable in the region, limits the amount of credit exposure with any one financial institution and conducts ongoing evaluations of the credit worthiness of the financial institutions with which it does business. However, a banking crisis, bankruptcy or insolvency of banks that process or hold the Company's funds, or sanctions may result in the loss of deposits or adversely affect the Company's ability to complete banking transactions, which could adversely affect the Company's business and financial condition.

Trade receivables are generally dispersed across many clients operating in different industries and geographies; therefore, concentration of credit risk is limited. Historically, credit losses and write-offs of trade receivables have not been material to the consolidated financial statements. If the Company's clients enter bankruptcy protection or otherwise take steps to alleviate their financial distress, the Company's credit losses and write-offs of trade receivables could increase, which would negatively impact its results of operations.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

*Foreign currency risk* — The Company's global operations are conducted predominantly in U.S. dollars. Other than U.S. dollars, the Company generates revenues in various currencies, principally in euros, British pounds, Swiss francs, Mexican pesos and Canadian dollars and incurs expenditures principally in euros, Polish zlotys, Indian rupees, British pounds, Mexican pesos, Colombian pesos, Hungarian forints, Swiss francs, and Canadian dollars. The Company's international operations expose it to risk of adverse fluctuations in foreign currency exchange rates through the remeasurement of foreign currency denominated assets and liabilities (both third-party and intercompany) and translation of earnings and cash flows into U.S. dollars. The Company has a hedging program whereby it enters into a series of foreign exchange forward contracts with durations of twelve months or less that are designated as cash flow hedges of forecasted Polish zloty, Indian rupee, Hungarian forint and Mexican peso transactions. See Note 6 "Derivative Financial Instruments*"* for further information on the Company's hedging program.

*Interest rate risk* — The Company is exposed to market risk from changes in interest rates. Exposure to interest rate risk results primarily from variable rates related to cash and cash equivalent deposits, short-term investments and the Company's borrowings, mainly under the 2021 Credit Agreement (and 2025 Credit Agreement subsequent to October 3, 2025), which is subject to a variety of rates depending on the type and timing of funds borrowed (See Note 8 "Debt"). The Company does not believe it is exposed to material direct risks associated with changes in interest rates related to these deposits, investments and borrowings.

**Adoption of New Accounting Standards**

There were no recently adopted accounting standards which had a material impact on the Company's consolidated financial statements.

**Pending Accounting Standards**

From time to time, new accounting pronouncements are issued by the FASB or other standards-setting bodies that the Company will adopt according to the various timetables the FASB specifies. Unless otherwise discussed below, the Company believes the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial statements upon adoption.

In September 2025, the FASB issued ASU No. 2025-06, *Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software*. This update is intended to modernize software accounting guidance by removing references to software development project stages and requiring entities to capitalize software costs when management has (i) authorized and committed to funding the software project and (ii) it is probable that the project will be completed and the software will be used to perform the function intended. The new guidance is effective for annual periods beginning after December 15, 2027, and interim periods within those annual periods. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently assessing the timing and impact of adopting this ASU.

**2.&nbsp;&nbsp;&nbsp;&nbsp;IMPACT OF THE INVASION OF UKRAINE**

On February 24, 2022, Russian forces attacked Ukraine and its people, and through the issuance date of these interim financial statements, there has been no resolution to this attack. As of September 30, 2025, the Company had $58.2 million of Property and equipment, net in Ukraine consisting of a building classified as construction-in-progress located in Kyiv with a net book value of $52.3 million, laptops with a net book value of $3.8 million, most of which are in the possession of employees, various office furniture, equipment and supplies with a net book value of $2.0 million, and leasehold improvements located throughout Ukraine with a net book value of $0.1 million. Additionally, as of September 30, 2025, the Company had Operating lease right-of-use assets located throughout Ukraine with a net book value of $3.9 million. Through the issuance date of these interim financial statements, the Company is not aware of any significant damage to its long-lived assets in Ukraine and the Company expects to continue to use these assets as part of its global delivery model.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

On March 4, 2022, the Company announced a $100.0 million humanitarian commitment to support its employees and their families in and displaced from Ukraine. This humanitarian commitment is in addition to donations from EPAM's clients and employees and the work of EPAM volunteers on the ground. The Company's spending under this commitment included special cash payments to support impacted employees, financial and medical support for impacted families, and donations to third-party humanitarian organizations. During the three and nine months ended September 30, 2025, the Company expensed $4.0 million and $12.2 million, respectively, related to this commitment. Of the expensed amounts for the three and nine months ended September 30, 2025, $0.6 million and $1.8 million, respectively, is classified in Cost of revenues (exclusive of depreciation and amortization), and $3.4 million and $10.4 million, respectively, is classified in Selling, general and administrative expenses on the condensed consolidated financial statements. During the three and nine months ended September 30, 2024, the Company expensed $3.6 million and $9.5 million, respectively, related to this commitment. Of the expensed amounts for the three and nine months ended September 30, 2024, $0.6 million and $1.8 million, respectively, is classified in Cost of revenues (exclusive of depreciation and amortization), and $3.0 million and $7.7 million, respectively, is classified in Selling, general and administrative expenses on the condensed consolidated financial statements. As of September 30, 2025, the Company has approximately $12.5 million remaining to be expensed under this humanitarian commitment.

**3. ACQUISITIONS**

**2025 Acquisition -** During the nine months ended September 30, 2025, the Company completed one acquisition with a total purchase price of $8.8 million including contingent consideration with acquisition-date fair value of $0.9 million. This acquisition expanded EPAM's AI-enabled business operations capabilities, as well as added $4.0 million of intangible assets, consisting of customer relationships. Pro forma results of operations have not been presented because the effect of these acquisitions on the Company's condensed consolidated financial statements was not material.

**First Derivative** — On December 2, 2024, the Company acquired First Derivative Ltd (together with its subsidiaries, "First Derivative") for a purchase price of $300.7 million. First Derivative is a Northern Ireland-headquartered managed services and consulting business for the capital markets industry with major delivery capability in the U.K., Ireland, North America and APAC.

**NEORIS** — On November 1, 2024, the Company acquired 99.7% of the outstanding shares of Neoris N.V. (together with its subsidiaries, "NEORIS") for a purchase price of $626.3 million. NEORIS is a global advanced technology consultancy with approximately 4,800 professionals across major talent hubs in Latin America, Spain and the U.S. NEORIS specializes in delivering complex digital engagement and transformation projects for clients in the Americas and Europe. On January 2, 2025, the Company completed the acquisition of the remaining 0.3% of Neoris N.V.'s outstanding shares for a purchase price of $1.4 million in cash.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed as of the date of each respective acquisition and updated for any changes as of September 30, 2025:

---

| | | |
|:---|:---|:---|
| | **First Derivative** | **NEORIS** |
| Cash and cash equivalents | $9160 | $63470 |
| Trade receivables and contract assets | 46410 | 79474 |
| Prepaid and other current assets | 10427 | 8390 |
| Goodwill | 171368 | 401314 |
| Intangible assets | 124809 | 259000 |
| Property and equipment and other noncurrent assets | 3999 | 22188 |
| &nbsp;&nbsp;&nbsp;**Total assets acquired** | $**366173** | $**833836** |
| Accounts payable, accrued expenses and other current liabilities | $31560 | $130510 |
| Other noncurrent liabilities | 33290 | 79545 |
| &nbsp;&nbsp;&nbsp;**Total liabilities assumed** | $**64850** | $**210055** |
| Noncontrolling interest in consolidated subsidiaries | **—** | 1358 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net assets acquired** | $**301323** | $**622423** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

During the nine months ended September 30, 2025, the Company recorded an increase to purchase price of $0.6 million for First Derivative related to the completion of purchase price adjustments for cash, indebtedness, and net working capital and also adjusted certain working capital accounts resulting in a combined increase in the value of acquired goodwill of $0.9 million. For the acquisition of First Derivative, the estimated fair values of the assets acquired and liabilities assumed are provisional and based on the information that was available as of the acquisition date. The Company expects to complete the purchase price allocations as soon as practicable but no later than one year from the acquisition date. The effect of adjustments recorded during the nine months ended September 30, 2025 that would have been recognized in a prior period if the adjustments to the preliminary amounts had been recognized as of the acquisition date of First Derivative was not material.

During the nine months ended September 30, 2025, the Company recorded a reduction to purchase price of $3.9 million for NEORIS related to the completion of purchase price adjustments for cash, indebtedness, and net working capital and also adjusted the fair value of assumed contingent consideration and certain working capital accounts resulting in a combined decrease in the value of acquired goodwill of $5.4 million. For the acquisition of NEORIS, the estimated fair values of the assets acquired, liabilities assumed and noncontrolling interest are provisional and based on the information that was available as of the acquisition date. The Company expects to complete the purchase price allocations as soon as practicable but no later than one year from the acquisition date. The effect of adjustments recorded during the nine months ended September 30, 2025 that would have been recognized in a prior period if the adjustments to the preliminary amounts had been recognized as of the acquisition date of NEORIS was not material.

As of September 30, 2025, the following table presents the estimated fair values and useful lives of intangible assets acquired from First Derivative and NEORIS:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **First Derivative** | **First Derivative** | **NEORIS** | **NEORIS** |
| | **Weighted Average Useful Life (in years)** | **Amount** | **Weighted Average Useful Life (in years)** | **Amount** |
| Customer relationships | 8 | $118441 | 8 | $249000 |
| Trade names | 5 | 6368 | 5 | 10000 |
| &nbsp;&nbsp;**Total** |  | $**124809** |  | $**259000** |

---

The goodwill recognized as a result of the First Derivative acquisition is attributable to synergies expected to be achieved by enhancing EPAM's industry experience and jointly delivering a comprehensive set of AI-enabled capabilities in the financial services vertical, expected future contracts, the assembled workforce acquired and other factors. The goodwill recognized as a result of the NEORIS acquisition is attributable to synergies expected to be achieved by expanding the Company's ability to support clients across Latin America, expected future contracts, the assembled workforce acquired and other factors. The goodwill recognized as a result of these acquisitions is not expected to be deductible for income tax purposes*.***

**Other 2024 Acquisitions -** During the year ended December 31, 2024, in addition to NEORIS and First Derivative, the Company completed three other acquisitions with a total purchase price of $74.2 million including contingent consideration with acquisition-date fair value of $9.8 million. These acquisitions expanded EPAM's geographical reach across Latin America and Europe, enhanced its capabilities in Life Sciences analytics, as well as added $20.3 million of intangible assets, consisting mainly of customer relationships. Pro forma results of operations have not been presented because the effect of these acquisitions on the Company's condensed consolidated financial statements was not material.

**4. GOODWILL**

Goodwill by reportable segment was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Americas** | **Europe** | **Total** |
| **Balance as of January 1, 2025** | $**652066** | $**529509** | $**1181575** |
| &nbsp;&nbsp;&nbsp;&nbsp;2025 Acquisition | 3197 |  | 3197 |
| &nbsp;&nbsp;&nbsp;&nbsp;NEORIS purchase accounting adjustments | (4460) | (982) | (5442) |
| &nbsp;&nbsp;&nbsp;&nbsp;First Derivative purchase accounting adjustments | 195 | 730 | 925 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other 2024 Acquisitions purchase accounting adjustments | 368 | 392 | 760 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of net foreign currency exchange rate changes | 872 | 27025 | 27897 |
| **Balance as of September 30, 2025** | $**652238** | $**556674** | $**1208912** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

There were no accumulated impairment losses in the Americas or Europe reportable segments as of September 30, 2025 or December 31, 2024.

**5. FAIR VALUE MEASUREMENTS** 

The Company carries certain assets and liabilities at fair value on a recurring basis on its condensed consolidated balance sheets. The following table presents the fair values of the Company's financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
| | **Balance** | **Level 1** | **Level 2** | **Level 3** |
| Foreign exchange derivative assets | $10623 | $— | $10623 | $— |
| &nbsp;&nbsp;&nbsp;**Total assets measured at fair value on a recurring basis** | $**10623** | $**—** | $**10623** | $**—** |
| Foreign exchange derivative liabilities | $3506 | $— | $3506 | $— |
| Contingent consideration liabilities | 22942 |  |  | 22942 |
| &nbsp;&nbsp;**Total liabilities measured at fair value on a recurring basis** | $**26448** | $**—** | $**3506** | $**22942** |

---

The following table presents the fair values of the Company's financial liabilities measured at fair value on a recurring basis as of December 31, 2024. The Company had no material financial assets measured at fair value on a recurring basis as of December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
| | **Balance** | **Level 1** | **Level 2** | **Level 3** |
| Foreign exchange derivative liabilities | $14650 | $— | $14650 | $— |
| Contingent consideration liabilities | 32978 | **—** |  | 32978 |
| &nbsp;&nbsp;**Total liabilities measured at fair value on a recurring basis** | $**47628** | $**—** | $**14650** | $**32978** |

---

The foreign exchange derivatives are valued using pricing models and discounted cash flow methodologies based on observable foreign exchange data at the measurement date. See Note 6 "Derivative Financial Instruments" for additional information regarding derivative financial instruments.

The fair value of the contingent consideration liabilities was determined using a probability-weighted expected return method and is based on the expected future payments to be made to the sellers of the acquired businesses in accordance with the provisions outlined in the respective purchase agreements. Although there is significant judgment involved, the Company believes its estimates and assumptions are reasonable. In determining fair value, the Company considered a variety of factors, including future performance of the acquired businesses using financial projections developed by the Company and market risk assumptions that were derived for revenue growth and earnings before interest and taxes. The Company estimated future payments using the earnout formula and performance targets specified in the purchase agreements and adjusted those estimates to reflect the probability of their achievement. Those weighted average estimated future payments were then discounted to present value using a rate based on the weighted average cost of capital of guideline companies. The discount rate used to determine the fair value of contingent consideration for the 2025 Acquisition was 15%. The discount rate used to determine the fair value of assumed contingent consideration for the NEORIS acquisition was 18%. The discount rates used to determine the fair value of contingent consideration for the Other 2024 Acquisitions ranged from a minimum of 12% to a maximum of 20%. Changes in financial projections, market risk assumptions, discount rates or probability assumptions related to achieving the various earnout criteria would result in a change in the fair value of the recorded contingent liabilities. Such changes, if any, are recorded within Interest and other income, net in the Company's condensed consolidated statements of income.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

A reconciliation of the beginning and ending balances of Level 3 contingent consideration liabilities using significant unobservable inputs for the nine months ended September 30, 2025 is as follows:

---

| | |
|:---|:---|
| | **Amount** |
| **Contingent consideration liabilities as of January 1, 2025** | $**32978** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition date fair value of contingent consideration - 2025 Acquisition | 935 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NEORIS purchase accounting adjustment | (1529) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in fair value of contingent consideration included in Interest and other income, net | (426) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of contingent consideration for previously acquired businesses | (9266) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of foreign currency exchange rate changes, net | 250 |
| **Contingent consideration liabilities as of September 30, 2025** | $**22942** |

---

**Financial Assets and Liabilities Not Measured at Fair Value on a Recurring Basis**

The following tables present the estimated fair values of the Company's financial assets and liabilities not measured at fair value on a recurring basis as of the dates indicated:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** |
| |<br>**Balance** |<br>**Estimated Fair Value** | **Level 1** | **Level 2** | **Level 3** |
| **<u>September 30, 2025</u>** | | | | | |
| **Financial Assets:** | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash equivalents: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money market funds | $5350 | $5350 | $5350 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Time deposits | 39526 | 39526 |  | 39526 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash equivalents | $44876 | $44876 | $5350 | $39526 | $— |
| **Financial Liabilities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings under the 2021 Credit Agreement | $25000 | $25000 | $— | $25000 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred consideration for asset acquisition | $34401 | $34401 | $— | $34401 | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **Fair Value Hierarchy** | **Fair Value Hierarchy** | **Fair Value Hierarchy** |
| |<br>**Balance** |<br>**Estimated Fair Value** | **Level 1** | **Level 2** | **Level 3** |
| **<u>December 31, 2024</u>** | | | | | |
| **Financial Assets:** | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash equivalents: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money market funds | $5200 | $5200 | $5200 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Time deposits | 16907 | 16907 |  | 16907 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash equivalents | $22107 | $22107 | $5200 | $16907 | $— |
| **Financial Liabilities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings under the 2021 Credit Agreement | $25000 | $25000 | $— | $25000 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred consideration for asset acquisition | $33187 | $33187 | $— | $33187 | $— |

---

**Non-Marketable Securities Without Readily Determinable Fair Values**

The Company holds investments in equity securities that do not have readily determinable fair values. These investments are recorded at cost and are remeasured to fair value based on certain observable price changes or impairment events as they occur. The carrying amount of these investments was $36.5 million and $38.5 million as of September 30, 2025 and December 31, 2024, respectively, and is classified as Other noncurrent assets in the Company's condensed consolidated balance sheets.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**6. DERIVATIVE FINANCIAL INSTRUMENTS**

In the normal course of business, the Company uses derivative financial instruments to manage the risk of fluctuations in foreign currency exchange rates. The Company has a hedging program whereby it enters into a series of foreign exchange forward contracts with durations of twelve months or less that are designated as cash flow hedges of forecasted Polish zloty, Indian rupee, Hungarian forint and Mexican peso transactions.

As of September 30, 2025, all of the Company's foreign exchange forward contracts were designated as hedges and there is no financial collateral (including cash collateral) required to be posted by the Company related to the foreign exchange forward contracts.

The fair value of derivative instruments on the Company's condensed consolidated balance sheets as of September 30, 2025 and December 31, 2024 were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **As of September 30, 2025** | **As of September 30, 2025** | **As of December 31, 2024** | **As of December 31, 2024** |
| |<br>**Balance Sheet Classification** | **Asset Derivatives** | **Liability Derivatives** | **Asset Derivatives** | **Liability Derivatives** |
| Foreign exchange forward contracts designated as hedging instruments | Prepaid expenses and other current assets | $10623 |  | $— |  |
|  | Accrued expenses and other current liabilities |  | $3506 |  | $14650 |

---

**7. LEASES**

The Company leases office space, corporate apartments, office equipment, and vehicles. Many of the Company's leases contain variable payments including changes in base rent and charges for common area maintenance or other miscellaneous expenses. Due to this variability, the cash flows associated with these variable payments are not included in the minimum lease payments used in determining the right-of-use assets and associated lease liabilities and are recognized in the period in which the obligation for such payments is incurred. The Company's leases have remaining lease terms ranging from 0.1 to 6.3 years. Certain lease agreements, mainly for office space, include options to extend or terminate the lease before the expiration date. The Company considers such options when determining the lease term when it is reasonably certain that the Company will exercise that option. The Company leases and subleases a portion of its office space to third parties. Lease income and sublease income were not material for the three and nine months ended September 30, 2025 and 2024.

During the three and nine months ended September 30, 2025 and 2024, the components of lease cost were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| |<br>**Income Statement Classification** | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp;Operating lease cost | Selling, general and administrative expenses | $11859 | $10893 | $35343 | $32579 |
| &nbsp;&nbsp;&nbsp;Variable lease cost | Selling, general and administrative expenses | 3112 | 2913 | 9287 | 7981 |
| &nbsp;&nbsp;&nbsp;Short-term lease cost | Selling, general and administrative expenses | 1237 | 881 | 3445 | 2787 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total lease cost** |  | $**16208** | $**14687** | $**48075** | $**43347** |

---

Supplemental cash flow information related to leases for the three and nine months ended September 30, 2025 and 2024 was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Cash paid for amounts included in the measurement of lease liabilities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows used for operating leases | $12703 | $11683 | $37349 | $34308 |
| **Right-of-use assets obtained in exchange for lease obligations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating leases | $251 | $837 | $8621 | $11823 |
| **Non-cash net increase due to lease modifications:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | $4048 | $5103 | $8039 | $11342 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | $4045 | $5245 | $8015 | $11376 |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

Weighted average remaining lease term and discount rate as of September 30, 2025 and 2024 were as follows:

---

| | | |
|:---|:---|:---|
| | **As of September 30, 2025** | **As of September 30, 2024** |
| **Weighted average remaining lease term, in years:** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 3.9 | 4.6 |
| **Weighted average discount rate:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 4.8% | 4.3% |

---

As of September 30, 2025, operating lease liabilities will mature as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Year ending December 31,** | **Lease Payments** |
| &nbsp;&nbsp;2025 (excluding nine months ended September 30, 2025) | $12154 |
| &nbsp;&nbsp;&nbsp;2026 | 42959 |
| &nbsp;&nbsp;&nbsp;2027 | 32538 |
| &nbsp;&nbsp;&nbsp;2028 | 25754 |
| &nbsp;&nbsp;&nbsp;2029 | 15021 |
| &nbsp;&nbsp;&nbsp;Thereafter | 13235 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total lease payments** | **141661** |
| &nbsp;&nbsp;&nbsp;Less: imputed interest | (11480) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $**130181** |

---

The Company had committed to payments of $7.0 million related to operating lease agreements that had not yet commenced as of September 30, 2025. These operating leases will commence on various dates during 2025 and 2026 with lease terms ranging from 6.0 to 7.0 years. The Company did not have any material finance lease agreements that had not yet commenced.

**8. DEBT**

**Revolving Credit Facility** — On October 21, 2021, the Company replaced its 2017 credit facility with a new unsecured credit agreement (the "2021 Credit Agreement") with PNC Bank, National Association; PNC Capital Markets LLC; Citibank N.A.; Wells Fargo Bank, National Association; Santander Bank, N.A.; and Raiffeisen Bank International AG (collectively the "Lenders"). The 2021 Credit Agreement provided for a revolving credit facility (the "2021 Revolving Facility") with a borrowing capacity of $700.0 million, with the potential to increase the borrowing capacity up to $1,000.0 million if certain conditions were met. The 2021 Credit Agreement was scheduled to mature on October 21, 2026.

Borrowings under the 2021 Revolving Facility could have been denominated in U.S. dollars or up to a maximum of $150.0 million equivalent in British pounds sterling, Canadian dollars, euros or Swiss francs and other currencies as may have been approved by the administrative agent and the Lenders. Borrowings under the 2021 Revolving Facility bore interest at either a base rate or euro-rate plus a margin based on the Company's leverage ratio. The base rate was equal to the highest of (a) the Overnight Bank Funding Rate, plus 0.5%, (b) the Prime Rate, or (c) the Daily Simple SOFR Rate, plus 1.0%, so long as the Daily Simple SOFR Rate is offered, ascertainable and not unlawful. As of September 30, 2025, the Company's outstanding borrowings were subject to a SOFR-based interest rate, which reset regularly at issuance, based on lending terms.

The 2021 Credit Agreement included customary business and financial covenants that may have restricted the Company's ability to make or pay dividends (other than certain intercompany dividends) if a potential or an actual event of default had occurred or would have been triggered. As of September 30, 2025, the Company was in compliance with all covenants contained in the 2021 Credit Agreement.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

The following table presents the outstanding debt and borrowing capacity of the Company under the 2021 Credit Agreement:

---

| | | |
|:---|:---|:---|
| | **As of <br>September 30,<br>2025** | **As of <br>December 31,<br>2024** |
| Outstanding debt | $25000 | $25000 |
| Interest rate | 5.1% | 5.4% |
| Available borrowing capacity | $675000 | $675000 |
| Maximum borrowing capacity | $700000 | $700000 |

---

On October 3, 2025, the Company entered into an amended and restated credit agreement (the "2025 Credit Agreement") with a syndicate of lenders that replaced the 2021 Credit Agreement. The 2025 Credit Agreement provides for a revolving credit facility (the "2025 Revolving Facility") with a borrowing capacity of $700.0 million, with the potential to increase the borrowing capacity up to $1,200.0 million if lenders agree to increase their commitments and the Company satisfies certain conditions. The 2025 Credit Agreement matures on October 3, 2030.

Borrowings under the 2025 Revolving Facility may be denominated in U.S. dollars or up to a maximum of $250.0 million equivalent in British pounds sterling, Canadian dollars, euros or Swiss francs and other currencies as may be approved by the lenders. Borrowings under the 2025 Revolving Facility bear interest at either a base rate or an alternative benchmark index for borrowings in currencies other than U.S. dollars. The base rate is equal to the highest of (a) the Overnight Bank Funding Rate, plus 0.5%, (b) the Prime Rate, or (c) the Daily Simple SOFR Rate, plus 1.0%, so long as the Daily Simple SOFR Rate is offered, ascertainable and not unlawful. The 2025 Credit Agreement includes customary business and financial covenants that may restrict the Company's ability to make or pay dividends (other than certain intercompany dividends) if a potential or actual event of default has occurred or would be triggered.

**9. COST OPTIMIZATION PROGRAMS**

During the quarter ended June 30, 2025, the Company initiated the 2025 Cost Optimization Program to improve utilization and profitability. This program is expected to include workforce reductions. The Company expects to complete all restructuring actions commenced under the 2025 Cost Optimization Program by the end of the first quarter of 2026 and to incur additional charges of approximately $14.0 million. The actual amount and timing of severance and other costs are dependent in part upon local country consultation processes and regulations and may differ from our current expectations and estimates.

During the quarter ended June 30, 2024, the Company initiated the 2024 Cost Optimization Program to streamline operations and optimize corporate functions. This program included workforce reductions and contract terminations. As of June 30, 2025, the Company had completed all restructuring actions commenced under the 2024 Cost Optimization Program.

During the quarter ended September 30, 2023, the Company initiated the 2023 Cost Optimization Program to streamline operations and optimize corporate functions. This program included workforce reductions and closure of underutilized facilities. As of June 30, 2024, the Company had completed all restructuring actions commenced under the 2023 Cost Optimization Program.

The total costs related to the Cost Optimization Programs are classified in Selling, general and administrative expenses in the condensed consolidated statements of income. The Company did not allocate these charges to individual segments as they are not considered by the chief operating decision maker during the review of segment results. Accordingly, such expenses are presented in our segment reporting as part of "Other unallocated expenses" (See Note 16 "Segment Information").

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

Activity in the Company's restructuring reserves was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Balance at December 31, 2024** | **Charges** | **Payments Made** | **Balance at September 30, 2025** |
| *2025 Cost Optimization Program* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Employee separation costs | $— | $26725 | $(20991) | $5734 |
| *2024 Cost Optimization Program* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Employee separation costs | 1763 | 6057 | (7266) | 554 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $**1763** | $**32782** | $**(28257)** | $**6288** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Balance at December 31, 2023** | **Charges** | **Payments Made** | **Balance at September 30, 2024** |
| *2024 Cost Optimization Program* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Employee separation costs | $— | $17132 | $(13506) | $3626 |
| &nbsp;&nbsp;&nbsp;Contract termination charges |  | 286 |  | 286 |
| *2023 Cost Optimization Program* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Employee separation costs | 6966 | 9015 | (15981) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $**6966** | $**26433** | $**(29487)** | $**3912** |

---

**10. REVENUES**

**Disaggregation of Revenues**

The following tables present the disaggregation of the Company's revenues by client location, including a reconciliation of the disaggregated revenues with the reportable segments (Note 16 "Segment Information") for the periods indicated:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Client Locations</u>** | | | |
| &nbsp;&nbsp;&nbsp;Americas | $757980 | $50650 | $808630 |
| &nbsp;&nbsp;&nbsp;EMEA | 41278 | 514461 | 555739 |
| &nbsp;&nbsp;&nbsp;APAC | 611 | 29393 | 30004 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**799869** | $**594504** | $**1394373** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Client Locations</u>** | | | |
| &nbsp;&nbsp;&nbsp;Americas | $2251226 | $139122 | $2390348 |
| &nbsp;&nbsp;&nbsp;EMEA | 112100 | 1465563 | 1577663 |
| &nbsp;&nbsp;&nbsp;APAC | 1111 | 80386 | 81497 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**2364437** | $**1685071** | $**4049508** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Client Locations</u>** | | | |
| &nbsp;&nbsp;&nbsp;Americas | $669582 | $27585 | $697167 |
| &nbsp;&nbsp;&nbsp;EMEA | 34679 | 410188 | 444867 |
| &nbsp;&nbsp;&nbsp;APAC | 352 | 25141 | 25493 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**704613** | $**462914** | $**1167527** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Client Locations</u>** | | | |
| &nbsp;&nbsp;&nbsp;Americas | $2002942 | $78344 | $2081286 |
| &nbsp;&nbsp;&nbsp;EMEA | 103220 | 1222215 | 1325435 |
| &nbsp;&nbsp;&nbsp;APAC | 1809 | 71059 | 72868 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**2107971** | $**1371618** | $**3479589** |

---

The following tables present the disaggregation of the Company's revenues by industry vertical, including a reconciliation of the disaggregated revenues with the reportable segments (Note 16 "Segment Information") for the periods indicated:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Industry Verticals</u>** | | | |
| &nbsp;&nbsp;&nbsp;Financial Services | $150573 | $187228 | $337801 |
| &nbsp;&nbsp;&nbsp;Consumer Goods, Retail & Travel | 122673 | 153354 | 276027 |
| &nbsp;&nbsp;&nbsp;Software & Hi-Tech | 143191 | 68965 | 212156 |
| &nbsp;&nbsp;&nbsp;Business Information & Media | 116848 | 50782 | 167630 |
| &nbsp;&nbsp;&nbsp;Life Sciences & Healthcare | 124943 | 34251 | 159194 |
| &nbsp;&nbsp;&nbsp;Emerging Verticals | 141641 | 99924 | 241565 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**799869** | $**594504** | $**1394373** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Industry Verticals</u>** | | | |
| &nbsp;&nbsp;&nbsp;Financial Services | $448475 | $531604 | $980079 |
| &nbsp;&nbsp;&nbsp;Consumer Goods, Retail & Travel | 356090 | 443499 | 799589 |
| &nbsp;&nbsp;&nbsp;Software & Hi-Tech | 423163 | 183737 | 606900 |
| &nbsp;&nbsp;&nbsp;Business Information & Media | 348912 | 155658 | 504570 |
| &nbsp;&nbsp;&nbsp;Life Sciences & Healthcare | 375859 | 94794 | 470653 |
| &nbsp;&nbsp;&nbsp;Emerging Verticals | 411938 | 275779 | 687717 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**2364437** | $**1685071** | $**4049508** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Industry Verticals</u>** | | | |
| &nbsp;&nbsp;&nbsp;Financial Services | $129339 | $125296 | $254635 |
| &nbsp;&nbsp;&nbsp;Consumer Goods, Retail & Travel | 107866 | 143259 | 251125 |
| &nbsp;&nbsp;&nbsp;Software & Hi-Tech | 131145 | 46928 | 178073 |
| &nbsp;&nbsp;&nbsp;Business Information & Media | 115121 | 52273 | 167394 |
| &nbsp;&nbsp;&nbsp;Life Sciences & Healthcare | 120659 | 21675 | 142334 |
| &nbsp;&nbsp;&nbsp;Emerging Verticals | 100483 | 73483 | 173966 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**704613** | $**462914** | $**1167527** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Industry Verticals</u>** | | | |
| &nbsp;&nbsp;&nbsp;Financial Services | $377000 | $364740 | $741740 |
| &nbsp;&nbsp;&nbsp;Consumer Goods, Retail & Travel | 339556 | 423026 | 762582 |
| &nbsp;&nbsp;&nbsp;Software & Hi-Tech | 392600 | 127727 | 520327 |
| &nbsp;&nbsp;&nbsp;Business Information & Media | 332602 | 170872 | 503474 |
| &nbsp;&nbsp;&nbsp;Life Sciences & Healthcare | 362983 | 59644 | 422627 |
| &nbsp;&nbsp;&nbsp;Emerging Verticals | 303230 | 225609 | 528839 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**2107971** | $**1371618** | $**3479589** |

---

The following tables present the disaggregation of the Company's revenues by contract type including a reconciliation of the disaggregated revenues with the Company's reportable segments (Note 16 "Segment Information") for the periods indicated:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Contract Types</u>** | | | |
| &nbsp;&nbsp;&nbsp;Time-and-material | $662650 | $456410 | $1119060 |
| &nbsp;&nbsp;&nbsp;Fixed-price | 131497 | 136602 | 268099 |
| &nbsp;&nbsp;&nbsp;Licensing and other revenues | 5722 | 1492 | 7214 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**799869** | $**594504** | $**1394373** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Contract Types</u>** | | | |
| &nbsp;&nbsp;&nbsp;Time-and-material | $1957852 | $1290314 | $3248166 |
| &nbsp;&nbsp;&nbsp;Fixed-price | 387803 | 390457 | 778260 |
| &nbsp;&nbsp;&nbsp;Licensing and other revenues | 18782 | 4300 | 23082 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**2364437** | $**1685071** | $**4049508** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Contract Types</u>** | | | |
| &nbsp;&nbsp;&nbsp;Time-and-material | $596111 | $372056 | $968167 |
| &nbsp;&nbsp;&nbsp;Fixed-price | 102239 | 89276 | 191515 |
| &nbsp;&nbsp;&nbsp;Licensing and other revenues | 6263 | 1582 | 7845 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**704613** | $**462914** | $**1167527** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Contract Types</u>** | | | |
| &nbsp;&nbsp;&nbsp;Time-and-material | $1793852 | $1099462 | $2893314 |
| &nbsp;&nbsp;&nbsp;Fixed-price | 296602 | 266888 | 563490 |
| &nbsp;&nbsp;&nbsp;Licensing and other revenues | 17517 | 5268 | 22785 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**2107971** | $**1371618** | $**3479589** |

---

**Timing of Revenue Recognition**

The following tables present the timing of revenue recognition reconciled with the Company's reportable segments (Note 16 "Segment Information") for the periods indicated:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Timing of Revenue Recognition</u>** | | | |
| &nbsp;&nbsp;&nbsp;Transferred over time | $795809 | $594377 | $1390186 |
| &nbsp;&nbsp;&nbsp;Transferred at a point of time | 4060 | 127 | 4187 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**799869** | $**594504** | $**1394373** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Timing of Revenue Recognition</u>** | | | |
| &nbsp;&nbsp;&nbsp;Transferred over time | $2349990 | $1684331 | $4034321 |
| &nbsp;&nbsp;&nbsp;Transferred at a point of time | 14447 | 740 | 15187 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**2364437** | $**1685071** | $**4049508** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Timing of Revenue Recognition</u>** | | | |
| &nbsp;&nbsp;&nbsp;Transferred over time | $701014 | $461923 | $1162937 |
| &nbsp;&nbsp;&nbsp;Transferred at a point of time | 3599 | 991 | 4590 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**704613** | $**462914** | $**1167527** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

---

| | | | |
|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Reportable Segments** | **Reportable Segments** | |
| | **Americas** | **Europe** |<br>**Consolidated Revenues** |
| **<u>Timing of Revenue Recognition</u>** | | | |
| &nbsp;&nbsp;&nbsp;Transferred over time | $2097251 | $1368155 | $3465406 |
| &nbsp;&nbsp;&nbsp;Transferred at a point of time | 10720 | 3463 | 14183 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**2107971** | $**1371618** | $**3479589** |

---

During the three and nine months ended September 30, 2025, the Company recognized $21.6 million and $15.5 million, respectively, of revenues from performance obligations satisfied in previous periods compared to $1.6 million and $15.0 million during the three and nine months ended September 30, 2024, respectively.

The following table includes the estimated revenues expected to be recognized in the future related to performance obligations that are partially or fully unsatisfied as of September 30, 2025. The Company applies a practical expedient and does not disclose the value of unsatisfied performance obligations for contracts (i) that have an original expected duration of one year or less and (ii) for which it recognizes revenues at the amount to which it has the right to invoice for services provided.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Less than 1 year** | **1 Year** | **2 Years** | **3 Years** | **Total** |
| **<u>Contract Type</u>** | | | | | |
| Fixed-price | $39346 | $2506 | $— | $— | $41852 |

---

The Company applies a practical expedient and does not disclose the amount of the transaction price allocated to the remaining performance obligations nor provide an explanation of when the Company expects to recognize that amount as revenue for certain variable consideration.

**Contract Balances**

The following table provides information on the classification of contract assets and liabilities in the condensed consolidated balance sheets:

---

| | | |
|:---|:---|:---|
| | **As of <br>September 30,<br>2025** | **As of <br>December 31,<br>2024** |
| Contract assets included in Trade receivables and contract assets, net | $76796 | $52897 |
| Contract liabilities included in Accrued expenses and other current liabilities | $43884 | $59321 |
| Contract liabilities included in Other noncurrent liabilities | $630 | $741 |

---

Contract assets comprise amounts where the Company's right to bill is contingent on something other than the passage of time such as achievement of contractual milestones. Contract assets have increased from December 31, 2024 primarily due to contracts where the Company's right to bill is contingent upon achievement of contractual milestones. Contract liabilities comprise amounts collected from the Company's clients for revenues not yet earned and such amounts are anticipated to be recorded as revenues when services are performed in subsequent periods. Contract liabilities have decreased from December 31, 2024 primarily due to lower levels of advance collections.

During the three and nine months ended September 30, 2025, the Company recognized $7.3 million and $47.6 million, respectively, of revenues that were included in Accrued expenses and other current liabilities at December 31, 2024. During the three and nine months ended September 30, 2024, the Company recognized $2.9 million and $20.3 million, respectively, of revenues that were included in Accrued expenses and other current liabilities at December 31, 2023.

**11. POLAND RESEARCH AND DEVELOPMENT INCENTIVES**

During the third quarter of 2024, the Company determined it was eligible for research and development ("R&D") tax relief in Poland which allows the Company to reduce its tax base through bonus deductions for specific costs, such as salaries and social security contributions for employees working on R&D projects. The Company is able to utilize the tax relief by first offsetting its corporate income tax liability and then, to the extent the tax relief exceeds its corporate income tax liability, reducing future remittances of personal income tax withholding for qualified employees.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

During the three and nine months ended September 30, 2025, the Company recognized benefits of $13.2 million and $38.2 million, respectively, related to R&D activities completed in Poland which were recorded as a reduction to Cost of revenues in the condensed consolidated statement of income. During the three and nine months ended September 30, 2024, the Company recognized benefits of $52.0 million of which $22.9 million related to 2023 R&D activities and $29.1 million related to R&D activities completed during the first nine months of 2024 which were recorded as a reduction to Cost of revenues in the condensed consolidated statements of income. As of September 30, 2025, $12.7 million of benefits were included in Prepaid and other current assets and $71.0 million of benefits were included in Other noncurrent assets on the condensed consolidated balance sheet related to the Poland R&D incentive. As of December 31, 2024, $23.1 million of benefits were included in Prepaid and other current assets and $34.3 million of benefits were included in Other noncurrent assets on the condensed consolidated balance sheet related to the Poland R&D incentive.

**12. STOCKHOLDERS' EQUITY**

**2025 Long-Term Incentive Plan** — On May 22, 2025, the Company's stockholders approved the EPAM Systems, Inc. 2025 Long Term Incentive Plan (the "2025 Plan") to be used to issue equity grants to Company personnel. The 2025 Plan is a new plan that replaces the EPAM Systems, Inc. 2015 Long Term Incentive Plan (the "2015 Plan"). The 2025 Plan reserves up to 1,585,970 shares of the Company's common stock for issuance, plus any shares subject to outstanding awards granted under the 2015 Plan and any predecessor plans that return to the share pool as a result of cancellation or forfeiture. The 2025 Plan will expire 10 years after the effective date and is administered by the Compensation Committee of the Company's Board of Directors.

**Stock-Based Compensation** 

The following table summarizes the components of stock-based compensation expense recognized in the Company's condensed consolidated statements of income for the periods indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Cost of revenues (exclusive of depreciation and amortization) | $21149 | $19576 | $63233 | $58870 |
| Selling, general and administrative expenses | 23455 | 22548 | 68385 | 63729 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $**44604** | $**42124** | $**131618** | $**122599** |

---

**Stock Options** 

Stock option activity under the Company's plans is set forth below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Number of<br>Options** | **Weighted Average<br>Exercise Price** | **Aggregate<br>Intrinsic Value** | **Weighted Average<br>Remaining Contractual Term (in years)** |
| **Options outstanding at January 1, 2025** | **1206** | $**165.78** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options exercised | (390) | $62.64 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options forfeited | (25) | $296.29 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options expired | (14) | $393.62 |  |  |
| **Options outstanding at September 30, 2025** | **777** | $**209.25** | $**14705** | 4.3 |
| Options vested and exercisable as of September 30, 2025 | 658 | $193.91 | $14705 | 3.7 |
| Options expected to vest as of September 30, 2025 | 115 | $294.30 | $— | 7.7 |

---

As of September 30, 2025, $7.5 million of total remaining unrecognized stock-based compensation cost related to unvested stock options, net of estimated forfeitures, is expected to be recognized over the weighted-average remaining requisite service period of 1.8 years.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**Restricted Stock Units**

*Service-Based Awards*

The table below summarizes activity related to the Company's equity-classified and liability-classified service-based awards for the nine months ended September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | &nbsp;&nbsp;**Equity-Classified**<br>**Equity-Settled**<br>**Restricted Stock Units** | &nbsp;&nbsp;**Equity-Classified**<br>**Equity-Settled**<br>**Restricted Stock Units** | &nbsp;&nbsp;**Liability-Classified**<br>**Cash-Settled**<br>**Restricted Stock Units** | &nbsp;&nbsp;**Liability-Classified**<br>**Cash-Settled**<br>**Restricted Stock Units** |
| | &nbsp;&nbsp;**Number of**<br>**Shares**  | **Weighted Average Grant Date<br>Fair Value Per Share** | &nbsp;&nbsp;**Number of**<br>**Shares**  | **Weighted Average Grant Date<br>Fair Value Per Share** |
| **Unvested service-based awards outstanding at January 1, 2025** | **1212** | $**288.12** | **89** | $**298.84** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards granted | 838 | $181.87 | 52 | $182.72 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards modified | (2) | $301.10 | 2 | $185.73 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards vested | (376) | $295.98 | (36) | $303.25 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards forfeited/cancelled | (111) | $241.32 | (2) | $267.29 |
| **Unvested service-based awards outstanding at September 30, 2025** | **1561** | $**232.50** | **105** | $**239.07** |

---

As of September 30, 2025, $248.0 million of total remaining unrecognized stock-based compensation cost related to service-based equity-classified restricted stock units ("RSUs"), net of estimated forfeitures, is expected to be recognized over the weighted-average remaining requisite service period of 2.5 years.

As of September 30, 2025, $12.6 million of total remaining unrecognized stock-based compensation cost related to service-based liability-classified cash-settled RSUs, net of estimated forfeitures, is expected to be recognized over the weighted-average remaining requisite service period of 2.5 years.

The liability associated with the service-based liability-classified RSUs as of September 30, 2025 and December 31, 2024, was $1.6 million and $4.8 million, respectively, and was classified as Accrued compensation and benefits expenses in the condensed consolidated balance sheets.

*Performance-Based Awards*

The table below summarizes activity related to the Company's performance-based awards for the nine months ended September 30, 2025:

---

| | | |
|:---|:---|:---|
| | &nbsp;&nbsp;**Equity-Classified** <br>**Equity-Settled**<br>**Restricted Stock Units** | &nbsp;&nbsp;**Equity-Classified** <br>**Equity-Settled**<br>**Restricted Stock Units** |
| | &nbsp;&nbsp;**Number of**<br>**Shares**  | **Weighted Average Grant Date<br>Fair Value Per Share** |
| &nbsp;&nbsp;**Unvested performance-based awards outstanding at January 1, 2025** | **62** | $**310.37** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards granted | 88 | $211.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards vested | (4) | $488.48 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards forfeited/cancelled | (17) | $262.18 |
| &nbsp;&nbsp;**Unvested performance-based awards outstanding at September 30, 2025** | **129** | $**244.54** |

---

In addition, as of September 30, 2025, the Company has issued 97 thousand performance-based equity-classified RSUs which are not considered granted for accounting purposes as the future vesting conditions have not yet been determined and these awards are not reflected in the table above.

As of September 30, 2025, $15.5 million of total remaining unrecognized stock-based compensation cost related to performance-based equity-classified RSUs is expected to be recognized over the weighted-average remaining requisite service period of 1.8 years.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

During the three months ended March 31, 2025 and March 31, 2024, the Company granted to its named executive officers and certain other members of senior management performance-based equity-classified RSU awards that vest after 3 years, contingent on meeting certain financial performance targets, market conditions and continued service. The financial performance targets are set by the Compensation Committee of the Board of Directors at the beginning of each year. For the portion of the awards subject to market conditions, fair value was determined using a Monte Carlo valuation model. The portion of the awards associated with financial performance in future years for which the financial performance targets have not yet been determined are not considered granted for accounting purposes. There were 71 thousand such awards as of September 30, 2025.

**Employee Stock Purchase Plan** 

The 2021 Employee Stock Purchase Plan ("ESPP") enables eligible employees to purchase shares of EPAM's common stock at a discount at the end of each designated offering period, which occurs every six months ending April 30th and October 31st. The purchase price is equal to 85% of the fair market value of a share of EPAM's common stock on the first date of an offering or the date of purchase, whichever is lower. During the nine months ended September 30, 2025, the ESPP participants purchased 107 thousand shares of common stock under the ESPP. During the nine months ended September 30, 2024, the ESPP participants purchased 85 thousand shares of common stock under the ESPP.

The Company recognizes compensation expense related to share issuances pursuant to the ESPP on a straight-line basis over the six-month offering period. For the three and nine months ended September 30, 2025, the Company recognized $2.5 million and $7.5 million, respectively, of stock-based compensation expense related to the ESPP. For the three and nine months ended September 30, 2024, the Company recognized $2.3 million and $7.5 million, respectively, of stock-based compensation expense related to the ESPP. As of September 30, 2025, total unrecognized stock-based compensation cost related to the ESPP was $0.9 million, which is expected to be recognized over a period of 0.1 years.

**Share Repurchases** 

On August 1, 2024, the Board of Directors authorized a share repurchase program (the "2024 Repurchase Program") for up to $500.0 million of the Company's outstanding common stock. The Company could repurchase shares of its common stock on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The timing and total amount of stock repurchases depended upon business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. As of September 30, 2025, the Company exhausted the $500.0 million available for purchases of the Company's common stock under the 2024 Repurchase Program. Prior to the authorization of the 2024 Repurchase Program, the Company repurchased common stock under the 2023 Repurchase Program and exhausted the $500.0 million authorized under that program as of June 30, 2024.

During the three and nine months ended September 30, 2025, the Company repurchased 493 thousand and 2,376 thousand shares of its common stock for $82.1 million and $437.0 million, respectively, in cash. During the three and nine months ended September 30, 2024, the Company repurchased 245 thousand and 1,801 thousand shares of its common stock for $50.0 million and $385.0 million, respectively, in cash. All of the repurchased shares have been retired.

On October 16, 2025, the Board of Directors authorized a new share repurchase program (the "2025 Repurchase Program") for up to $1,000.0 million of the Company's outstanding common stock. The Company may repurchase shares of its common stock on a discretionary basis from time to time through open-market purchases, privately negotiated transactions or other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The timing and total amount of stock repurchases will depend upon business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The share repurchase program has a term of 24 months, may be suspended or discontinued at any time, and does not obligate the Company to acquire any amount of common stock.

**13. INCOME TAXES**

In determining its interim provision for income taxes, the Company uses an estimated annual effective tax rate, which is based on expected annual profit before tax, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

The Company's worldwide effective tax rate for the three months ended September 30, 2025 and 2024 was 25.6% and 28.1%, respectively, and 25.8% and 21.4% during the nine months ended September 30, 2025 and 2024, respectively. The Company recorded a tax shortfall upon vesting or exercise of stock awards of $0.2 million and $0.8 million during the three and nine months ended September 30, 2025, respectively. The Company recorded a tax shortfall upon vesting or exercise of stock awards of $0.3 million during the three months ended September 30, 2024 and excess tax benefits upon vesting or exercise of stock awards of $20.5 million during the nine months ended September 30, 2024. The effective tax rate during the three and nine months ended September 30, 2024 was negatively impacted by the accounting treatment of the receipt of government incentives related to conducting R&D activities in Poland, which resulted in a 2.3% and 1.0% increase in the effective tax rate, respectively, and the non-deductibility of certain acquisition costs for tax purposes which resulted in a 1.4% and 0.6% increase in the effective tax rate, respectively.

On July 4, 2025, the U.S. federal government enacted tax reform legislation, commonly referred to as the One Big Beautiful Bill Act ("the Act"), which includes a broad range of tax reform provisions. The tax law changes included in the Act did not have a material impact on the Company's effective tax rate for the three and nine months ended September 30, 2025; however, the Company expects an acceleration of certain deductions resulting in a $26.2 million reduction in cash tax payments associated with the 2025 tax year.

**14. EARNINGS PER SHARE**

Basic earnings per share is computed by dividing net income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, unvested equity-settled RSUs and the stock to be issued under the Company's ESPP. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share of common stock as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Numerator for basic and diluted earnings per share:** |  |  |  |  |
| Net income | $106816 | $136346 | $268324 | $351234 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Numerator for basic and diluted earnings per share | $106816 | $136346 | $268324 | $351234 |
| **Denominator:** |  |  |  |  |
| Weighted average common shares for basic earnings per share | 55557 | 56910 | 56214 | 57445 |
| Net effect of dilutive stock options, restricted stock units, restricted stock awards and stock issuable under the ESPP | 260 | 515 | 320 | 721 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares for diluted earnings per share | 55817 | 57425 | 56534 | 58166 |
| **Net income per share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.92 | $2.40 | $4.77 | $6.11 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $1.91 | $2.37 | $4.75 | $6.04 |

---

The number of shares underlying equity-based awards that were excluded from the calculation of diluted earnings per share as their effect would be anti-dilutive was 1,156 thousand and 1,184 thousand during the three and nine months ended September 30, 2025, respectively.

The number of shares underlying equity-based awards that were excluded from the calculation of diluted earnings per share as their effect would be anti-dilutive was 1,426 thousand and 1,056 thousand during the three and nine months ended September 30, 2024, respectively.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**15. COMMITMENTS AND CONTINGENCIES**

**Indemnification Obligations** — In the normal course of business, the Company is a party to a variety of agreements under which it may be obligated to indemnify the other party for certain matters. These obligations typically arise in contracts where the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations or covenants for certain matters, infringement of third-party intellectual property rights, data privacy violations, and certain tortious conduct in the course of providing services. The duration of these indemnifications varies, and in certain cases, is indefinite.

The Company is unable to reasonably estimate the maximum potential amount of future payments under these or similar agreements due to the unique facts and circumstances of each agreement and the fact that certain indemnifications provide for no limitation to the maximum potential future payments under the indemnification. Management is not aware of any such matters that would have a material effect on the condensed consolidated financial statements of the Company.

**Litigation** — From time to time, the Company is involved in litigation, claims or other contingencies arising in the ordinary course of business. The Company accrues a liability when a loss is considered probable and the amount can be reasonably estimated. When a material loss contingency is reasonably possible but not probable, the Company does not record a liability but instead discloses the nature and the amount of the claim, and an estimate of the loss or range of loss, if such an estimate can be made. Legal fees are expensed as incurred. In the opinion of management, the outcome of any existing claims and legal or regulatory proceedings, if decided adversely, is not expected to have a material effect on the Company's business, financial condition, results of operations or cash flows.

**Ukraine Humanitarian Commitment** — On March 4, 2022, EPAM announced that it has established a $100.0 million humanitarian commitment to support its employees in Ukraine and their families. As of September 30, 2025, the Company has $12.5 million remaining to be expensed related to this humanitarian commitment. See Note 2 "Impact of the Invasion of Ukraine" for more information regarding commitment to humanitarian aid for Ukraine.

**Deferred Consideration** — During the year ended December 31, 2022, the Company purchased software licenses for use in the regular course of business in exchange for an upfront payment and fixed, subsequent annual payments due over the next 4 years. This agreement was modified during the years ended December 31, 2023 and 2024. As of September 30, 2025, the undiscounted deferred consideration amounts owed totaled approximately $35.2 million and are expected to be paid as follows: $17.1 million during the remainder of 2025, and $18.1 million in 2026.

**Contractual Commitment** — On March 31, 2023, the Company entered into a 5-year agreement for cloud services through which it committed to spending at least $75.0 million over the term of the agreement. As of September 30, 2025, $52.1 million remains to be spent under this contractual commitment. The Company has the ability to cancel the commitment whereby it would incur a cancellation penalty of 20% of the remaining contractual commitment.

**16. SEGMENT INFORMATION**

The Company determines its business segments and reports segment information in accordance with how the Company's chief operating decision maker ("CODM") organizes the segments to evaluate performance, allocate resources and make business decisions. The Company's CODM is the chief executive officer. The Company manages its business primarily based on the managerial responsibility for its client base and market. As managerial responsibility for a particular client relationship generally correlates with the client's geographic location, there is a high degree of similarity between client locations and the geographic boundaries of the Company's reportable segments. In some cases, managerial responsibility for a particular client is assigned to a management team in another region and is usually based on the strength of the relationship between client executives and particular members of EPAM's senior management team. In such cases, the client's activity would be reported through the management team's reportable segment.

Starting in 2025, the Company renamed its North America segment to Americas. The new name reflects the evolving geographic footprint and growth of operations within the segment, particularly in Latin America. This constitutes a naming change only and no changes were made to amounts previously reported.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

Segment results are based on the segment's revenues and operating profit, where segment operating profit is defined as segment income from operations before unallocated costs. Expenses included in segment operating profit consist principally of direct selling and delivery costs as well as an allocation of certain shared services expenses. Intersegment transactions are excluded from the segment's revenues and operating profit on the basis that they are neither included in the measure of a segment's profit and loss results, nor considered by the CODM during the review of segment results. Certain corporate expenses are not allocated to specific segments as these expenses are not controllable at the segment level. Such expenses include certain types of professional fees, certain taxes included in operating expenses, compensation to non-employee directors and certain other general and administrative expenses, including compensation of specific groups of non-production employees. In addition, the Company does not allocate amortization of intangible assets acquired through business combinations, goodwill and other asset impairment charges, stock-based compensation expenses, acquisition-related costs and certain other one-time charges and benefits. These unallocated amounts are combined with total segment operating profit to arrive at consolidated income from operations as reported below in the reconciliation of segment operating profit to consolidated income before provision for income taxes. Additionally, management has determined that it is not practical to allocate identifiable assets by segment since such assets are used interchangeably among the segments.

The Company's CODM considers the operating results of each segment on a quarterly basis and uses segment operating profit predominantly to assess the performance of each segment by comparing the results of each segment with one another and to historical performance. When combined with certain other financial information, this enables the CODM to make decisions about the reporting structure, allocation of operating and capital resources, and compensation of certain employees.

During the year ended December 31, 2024, the Company revised its CODM report to enhance the presentation of segment expenses by category and to revise the allocation methodology for certain types of shared expenses. The following prior period amounts presented have been revised to align with the current methodology. No changes were made to historically reported segment revenues.

Segment revenues from external clients and segment operating profit, as well as a reconciliation of segment operating profit to consolidated income before provision for income taxes is presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** | **For the Three Months Ended September 30, 2025** |
| | **Americas** | **Europe** | **Total** |
| **Segment revenues** | $**799869** | $**594504** | $**1394373** |
| Less: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues (exclusive of depreciation and amortization) | 548161 | 421398 | 969559 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 106753 | 79767 | 186520 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 8656 | 4438 | 13094 |
| **Segment operating profit** | $**136299** | $**88901** | $**225200** |
| Unallocated costs: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense |  |  | (44604) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of purchased intangibles |  |  | (18220) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other acquisition-related expenses |  |  | (233) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other unallocated costs |  |  | (17200) |
| **Income from operations** |  |  | **144943** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and other income, net |  |  | 2302 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange loss |  |  | (3627) |
| **Income before provision for income taxes** |  |  | $**143618** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

---

| | | | |
|:---|:---|:---|:---|
| | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** | **For the Nine Months Ended September 30, 2025** |
| | **Americas** | **Europe** | **Total** |
| **Segment revenues** | $**2364437** | $**1685071** | $**4049508** |
| Less: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues (exclusive of depreciation and amortization) | 1643778 | 1200316 | 2844094 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 312270 | 230811 | 543081 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 27372 | 12940 | 40312 |
| **Segment operating profit** | $**381017** | $**241004** | $**622021** |
| Unallocated costs: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense |  |  | (131618) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of purchased intangibles |  |  | (53712) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other acquisition-related expenses |  |  | (1108) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other unallocated costs |  |  | (64834) |
| **Income from operations** |  |  | **370749** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and other income, net |  |  | 11635 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange loss |  |  | (20581) |
| **Income before provision for income taxes** |  |  | $**361803** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** | **For the Three Months Ended September 30, 2024** |
| | **Americas** | **Europe** | **Total** |
| **Segment revenues** | $**704613** | $**462914** | $**1167527** |
| Less: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues (exclusive of depreciation and amortization) | 447952 | 300572 | 748524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 90819 | 65543 | 156362 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 9120 | 4909 | 14029 |
| **Segment operating profit** | $**156722** | $**91890** | $**248612** |
| Unallocated costs: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense |  |  | (42124) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of purchased intangibles |  |  | (5707) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other acquisition-related expenses |  |  | (7106) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other unallocated costs |  |  | (16696) |
| **Income from operations** |  |  | **176979** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and other income, net |  |  | 13347 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange loss |  |  | (710) |
| **Income before provision for income taxes** |  |  | $**189616** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

---

| | | | |
|:---|:---|:---|:---|
| | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** | **For the Nine Months Ended September 30, 2024** |
| | **Americas** | **Europe** | **Total** |
| **Segment revenues** | $**2107971** | $**1371618** | $**3479589** |
| Less: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues (exclusive of depreciation and amortization) | 1410358 | 952551 | 2362909 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 269102 | 198110 | 467212 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 29578 | 15949 | 45527 |
| **Segment operating profit** | $**398933** | $**205008** | $**603941** |
| Unallocated costs: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense |  |  | (122599) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of purchased intangibles |  |  | (17477) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other acquisition-related expenses |  |  | (8802) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other unallocated costs |  |  | (46991) |
| **Income from operations** |  |  | **408072** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest and other income, net |  |  | 40425 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange loss |  |  | (1416) |
| **Income before provision for income taxes** |  |  | $**447081** |

---

For each reportable segment, selling, general and administrative expenses include the costs of salaries, bonuses, fringe benefits, bad debt, travel, employee relocations, legal and accounting services, insurance, facilities and overhead including operating leases, advertising and other promotional activities.

There were no clients that accounted for more than 10% of total segment revenues during the three and nine months ended September 30, 2025 and 2024. See Note 10 "Revenues" for additional disclosures of the Company's disaggregated revenues reconciled with the revenues from the Company's reportable segments.

***Geographic Area Information***

Long-lived assets presented in the table below include property and equipment, net of accumulated depreciation and amortization, and management has determined that it is not practical to allocate these assets by segment since such assets are used interchangeably among the segments. Physical locations and values of the Company's long-lived assets are presented below:

---

| | | |
|:---|:---|:---|
| | **As of <br>September 30,<br>2025** | **As of <br>December 31,<br>2024** |
| Ukraine | $58150 | $58865 |
| Belarus | 45060 | 45900 |
| United States | 29066 | 39403 |
| India | 14064 | 15367 |
| Poland | 10945 | 10605 |
| Hungary | 4609 | 4157 |
| United Kingdom | 4338 | 3936 |
| Other | 32589 | 29434 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $**198821** | $**207667** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

The table below presents information about the Company's revenues by client location for the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| United States | $716178 | $666851 | $2114616 | $1996566 |
| United Kingdom | 153366 | 126010 | 447533 | 389733 |
| Switzerland | 113258 | 104268 | 328179 | 304022 |
| Germany | 60265 | 53604 | 168363 | 153627 |
| Netherlands | 60709 | 45816 | 164745 | 142577 |
| Other locations | 290597 | 170978 | 826072 | 493064 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $**1394373** | $**1167527** | $**4049508** | $**3479589** |

---

**17. ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)**

The following table summarizes the changes in the accumulated balances for each component of accumulated other comprehensive income/(loss):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Foreign currency translation** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Beginning balance** | $**8796** | $**(67962)** | $**(103975)** | $**(43601)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation | (2948) | 39596 | 139194 | 8305 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit/(expense) | 2023 | (8822) | (27348) | (1892) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Foreign currency translation, net of tax** | **(925)** | **30774** | **111846** | **6413** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Ending balance** | $**7871** | $**(37188)** | $**7871** | $**(37188)** |
| **Cash flow hedging instruments** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Beginning balance** | $**13600** | $**1479** | $**(11265)** | $**7819** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized (loss)/gain in fair value | (3089) | 1592 | 29964 | (1797) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain reclassified into Cost of revenues (exclusive of depreciation and amortization) | (7516) | (4185) | (8392) | (9040) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss reclassified into Foreign exchange loss | 36 |  | 193 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit/(expense) | 2442 | 599 | (5027) | 2503 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Cash flow hedging instruments, net of tax** | **(8127)** | **(1994)** | **16738** | **(8334)** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Ending balance**<sup>(1)</sup> | $**5473** | $**(515)** | $**5473** | $**(515)** |
| **Defined benefit plans** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Beginning balance** | $**(1082)** | $**(2940)** | $**(1624)** | $**(3258)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Actuarial gains | 135 | 126 | 1154 | 439 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax (expense)/benefit |  |  | (477) | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Defined benefit plans, net of tax** | **135** | **126** | **677** | **444** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Ending balance** | $**(947)** | $**(2814)** | $**(947)** | $**(2814)** |
| **Accumulated other comprehensive income/(loss)** | $**12397** | $**(40517)** | $**12397** | $**(40517)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) As of September 30, 2025, the ending balance of net unrealized gain related to derivatives designated as cash flow hedges is expected to be reclassified into Cost of revenues (exclusive of depreciation and amortization) in the next twelve months.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**18. SUBSEQUENT EVENTS**

**Revolving Credit Facility —** On October 3, 2025, the Company entered into the 2025 Credit Agreement with a syndicate of lenders that replaced the 2021 Credit Agreement. See Note 8 "Debt" for further information.

**Share Repurchases —** On October 16, 2025, the Board of Directors authorized the 2025 Repurchase Program. See Note 12 "Stockholders' Equity" for further information.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

***Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations***

*You should read the following discussion and analysis of our financial condition and results of operations together with our Annual Report on Form 10-K for the year ended December 31, 2024 and the unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report. In addition to historical information, this discussion contains forward-looking statements that involve risks, uncertainties and assumptions that could cause actual results to differ materially from management's expectations. Factors that could cause such differences are discussed in the sections entitled "Forward-Looking Statements" in this item and in "Part I. Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024. We assume no obligation to update any of these forward-looking statements.*

*In this quarterly report, "EPAM," "EPAM Systems, Inc.," the "Company," "we," "us" and "our" refer to EPAM Systems, Inc. and its consolidated subsidiaries.*

*"EPAM" is a trademark of EPAM Systems, Inc. All other trademarks and service marks used herein are the property of their respective owners.*

**Executive Summary**

We have used our software engineering expertise to become a leading global provider of digital engineering, cloud and AI-enabled transformation services, as well as a leading business and experience consulting partner for global enterprises and ambitious startups. We address our clients' transformation challenges by fusing EPAM Continuum's integrated strategy, experience and technology consulting with our 30+ years of engineering execution to speed our clients' time to market and drive greater value from their digital investments.

We leverage AI and GenAI to deliver transformative solutions that accelerate our clients' digital innovation and enhance their competitive edge. Through platforms like EPAM AI/RUN™ and initiatives like DIALX Lab™, we integrate advanced AI technologies into tailored business strategies, driving significant industry impact and fostering continuous innovation.

Through increased specialization in focused verticals and a continued emphasis on strategic partnerships, we are able to deliver technology transformation from start to finish, leveraging agile methodologies, proven client collaboration frameworks, engineering excellence tools, hybrid teams and our award-winning proprietary global delivery platform.

Our clients depend on us to solve their complex technical challenges and rely on our expertise in core engineering, advanced technologies, digital design and intelligent enterprise development. We combine our software engineering heritage with strategic business and innovation consulting, design thinking, and physical-digital capabilities to deliver end-to-end digital transformation services for our clients. We focus on building long-term partnerships with our clients in a market that is constantly challenged by the pressures of digitization through our innovative strategy and scalable software solutions, integrated advisory, business consulting and experience design, and a continually evolving mix of advanced capabilities.

Our global delivery model and centralized support functions, combined with the benefits of scale from the shared use of fixed-cost resources, enhance our productivity levels and enable us to better manage the efficiency of our global operations. As a result, we have created a delivery base whereby our applications, tools, methodologies and infrastructure allow us to seamlessly deliver services and solutions from our global delivery centers to our clients across the world. Our teams of consultants, designers, architects, engineers and trainers have the capabilities and skill sets to deliver business results.

**Business Update Regarding the War in Ukraine**

On February 24, 2022, Russian forces attacked Ukraine and its people, and through the issuance date of these interim financial statements, there has been no resolution to this attack. EPAM's highest priority is the safety and security of its employees and their families in Ukraine as well as in the broader region, and we have continued to support relocating our employees to lower risk locations, both within Ukraine and to other countries where we operate. The vast majority of our Ukraine employees are in safe locations and operating at levels of productivity consistent with those achieved prior to the attack. As of September 30, 2025, Ukraine continues to be a significant delivery location with a large number of delivery professionals. Furthermore, we have maintained our $100 million humanitarian aid commitment to our people in Ukraine in addition to our other donations and volunteer efforts, and as of September 30, 2025, we have $12.5 million remaining to be expensed under this humanitarian commitment.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

The impact of Russia's invasion of Ukraine on our operations, personnel, and physical assets in Ukraine has had, and, along with any escalation of the war that includes Belarus' territory or military, could continue to have a material adverse effect on our operations. Actions taken by other countries, including new and stricter sanctions by Canada, the United Kingdom, the European Union, the U.S. and other companies and organizations against officials, individuals, regions, and industries in Belarus, and Belarus' responses to those sanctions, including counter-sanctions and other actions, have had and could continue to have a material adverse effect on our operations. Clients have and may continue to seek altered terms, conditions, and delivery locations for the performance of services, delay planned work or seek services from alternate providers, or suspend, terminate, fail to renew, or reduce existing contracts or services, which could have a material adverse effect on our financial condition. Some of our clients have implemented steps to block internet communications with Ukraine and Belarus to protect against potential cyberattacks or other information security threats, which has caused a material adverse effect on our ability to deliver our services to these clients from those locations. Such material adverse effects disrupt our delivery of services, cause us to shift all or portions of our work occurring in the region to other countries, restrict our ability to engage in certain projects in the region and serve certain clients in or from the region, and could negatively impact our personnel, operations, financial results and business outlook. Our Board of Directors and its committees continue their oversight of our strategic, geopolitical, and cybersecurity risks and the risks related to our geographic expansion. Our Board has received updates from management during both regular and special meetings, while also providing oversight of the risks associated with Russia's invasion of Ukraine and other strategic areas of importance related to the war.

*Moving Forward*

We continue to monitor and respond to the difficult conditions in Ukraine while maintaining a focus on our clients and long-term growth. We execute on our business continuity plans and adapt to developments as they occur to protect the safety of our people and address impacts on our delivery infrastructure, including reallocating work to other geographies within our global footprint. We engage with both our personnel and our clients when navigating delivery challenges while operating productively in a multitude of locations and providing consistent high-quality delivery to our clients. Our global delivery centers have sufficient resources, including infrastructure and capital, to support ongoing operations while continuing to focus on the safety and security of our employees and their families in Ukraine as well as in the broader region.

The implementation and execution of our business continuity plans, relocation costs, our humanitarian commitment to our people in Ukraine, and the cost of our phased exit from Russia resulted in materially increased expenses. Some of these expenses continued during this quarter and we expect some of these expenses will continue to occur in subsequent quarters for some time in the future.

We have no way to predict the progress or outcome of the war in Ukraine because the conflict and government reactions change quickly and are beyond our control. Prolonged military activities, broad-based sanctions and counter-sanctions, or escalation of the war that includes Belarus' territory or military could have a material adverse effect on our operations and financial condition. The information contained in this section is accurate as of the date hereof but may become outdated due to changing circumstances beyond our control or present awareness. For additional information on the various risks posed by the attack against Ukraine and the impact in the region as well as other risks to our business, please read "Part I. Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and "Part II. Item 1A. Risk Factors" in this quarterly report.

**Year-to-Date 2025 Developments and Trends**

For the first nine months of 2025, our revenues were $4.050 billion, an increase of 16.4% from $3.480 billion reported for the same period of 2024. Revenues have been positively impacted by improving demand for our services, acquisitions completed in 2024, and foreign exchange fluctuations. Income from operations as a percentage of revenues decreased to 9.2% for the nine months ended September 30, 2025 as compared to 11.7% for the nine months ended September 30, 2024, largely driven by lower government incentives related to conducting R&D activities in Poland and an increase in cost of revenues (exclusive of depreciation and amortization) as a percentage of revenues. Diluted earnings per share decreased to $4.75 for the nine months ended September 30, 2025 from $6.04 for the nine months ended September 30, 2024, principally resulting from a decrease in income from operations as well as reduced excess tax benefits upon vesting or exercise of equity awards.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**Critical Accounting Policies**

The discussion and analysis of our financial position and results of operations is based on our unaudited condensed consolidated financial statements which have been prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements in accordance with U.S. GAAP requires us to make estimates and judgments that may affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On a recurring basis, we evaluate our estimates and judgments, including those related to revenue recognition and related allowances, impairments of long-lived assets including intangible assets, goodwill and right-of-use assets, income taxes including the valuation allowance for deferred tax assets, and stock-based compensation. Actual results may differ materially from these estimates under different assumptions and conditions. In addition, our reported financial condition and results of operations could vary due to a change in the application of a particular accounting standard.

During the three and nine months ended September 30, 2025, there have been no material changes to our critical accounting policies as reported in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Results of Operations**

The following table sets forth a summary of our consolidated results of operations for the periods indicated. This information should be read together with our unaudited condensed consolidated financial statements and related notes included elsewhere in this quarterly report. The operating results in any period are not necessarily indicative of the results that may be expected for any future period.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2025** | **2024** | **2024** | **2025** | **2025** | **2024** | **2024** |
| | **(in thousands, except percentages and per share data)** | **(in thousands, except percentages and per share data)** | **(in thousands, except percentages and per share data)** | **(in thousands, except percentages and per share data)** | **(in thousands, except percentages and per share data)** | **(in thousands, except percentages and per share data)** | **(in thousands, except percentages and per share data)** | **(in thousands, except percentages and per share data)** |
| **Revenues** | $**1394373** | **100.0%** | $**1167527** | **100.0%** | $**4049508** | **100.0%** | $**3479589** | **100.0%** |
| &nbsp;&nbsp;&nbsp;Operating expenses: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues (exclusive of depreciation and amortization)<sup>(1)</sup> | 983169 | 70.5% | 763992 | 65.4% | 2899189 | 71.6% | 2409183 | 69.3% |
| &nbsp;&nbsp;&nbsp;&nbsp; Selling, general and administrative expenses<sup>(2)</sup> | 234948 | 16.8% | 206820 | 17.7% | 685546 | 16.9% | 599331 | 17.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 31313 | 2.3% | 19736 | 1.7% | 94024 | 2.3% | 63003 | 1.8% |
| **Income from operations** | **144943** | **10.4%** | **176979** | **15.2%** | **370749** | **9.2%** | **408072** | **11.7%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and other income, net | 2302 | 0.2% | 13347 | 1.1% | 11635 | 0.2% | 40425 | 1.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange loss | (3627) | (0.3)% | (710) | (0.1)% | (20581) | (0.5)% | (1416) | —% |
| &nbsp;&nbsp;**Income before provision for income taxes** | **143618** | **10.3%** | **189616** | **16.2%** | **361803** | **8.9%** | **447081** | **12.8%** |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 36802 | 2.6% | 53270 | 4.5% | 93479 | 2.3% | 95847 | 2.7% |
| **Net income** | $**106816** | **7.7%** | $**136346** | **11.7%** | $**268324** | **6.6%** | $**351234** | **10.1%** |
| Effective tax rate | 25.6% |  | 28.1% |  | 25.8% |  | 21.4% |  |
| Diluted earnings per share | $1.91 |  | $2.37 |  | $4.75 |  | $6.04 |  |

---

(1)Includes $21,149 and $19,576 of stock-based compensation expense for the three months ended September 30, 2025 and 2024, respectively, and $63,233 and $58,870 of stock-based compensation expense for the nine months ended September 30, 2025 and 2024, respectively.

(2)Includes $23,455 and $22,548 of stock-based compensation expense for the three months ended September 30, 2025 and 2024, respectively, and $68,385 and $63,729 of stock-based compensation expense for the nine months ended September 30, 2025 and 2024, respectively.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

***Consolidated Results Review***

*Revenues*

During the three months ended September 30, 2025, our total revenues increased by 19.4% to $1.394 billion compared to the corresponding period in 2024. During the three months ended September 30, 2025 as compared to the same period last year, revenues have been positively impacted by improving demand for our services, acquisitions completed in 2024 which contributed 10.5% to revenue growth, and fluctuations in foreign currency exchange rates which contributed 1.8% to revenue growth.

Revenues by client location for the three and nine months ended September 30, 2025 and 2024 were as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2025** | **2024** | **2024** | **2025** | **2025** | **2024** | **2024** |
|  | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** |
| Americas<sup>(1)</sup> | $808630 | 58.0% | $697167 | 59.7% | $2390348 | 59.0% | $2081286 | 59.8% |
| EMEA<sup>(2)</sup> | 555739 | 39.9% | 444867 | 38.1% | 1577663 | 39.0% | 1325435 | 38.1% |
| APAC<sup>(3)</sup> | 30004 | 2.1% | 25493 | 2.2% | 81497 | 2.0% | 72868 | 2.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**1394373** | **100.0%** | $**1167527** | **100.0%** | $**4049508** | **100.0%** | $**3479589** | **100.0%** |

---

(1)Americas includes revenues from clients in North, Central and South America.

(2)EMEA includes revenues from clients in Europe and the Middle East.

(3)APAC includes revenues from clients in East Asia, Southeast Asia and Australia.

During the three and nine months ended September 30, 2025, the United States continued to be our largest client location. During the three months ended September 30, 2025, revenues in the United States increased 7.4% to $716.2 million from $666.9 million in the third quarter of 2024, largely due to increased spending at certain large accounts in the region as well as revenues from our 2024 acquisitions. During the nine months ended September 30, 2025, revenues in the United States increased to $2.115 billion as compared to $1.997 billion in the same period of the prior year.

During the three months ended September 30, 2025, the top three revenue contributing countries by client location in EMEA were the United Kingdom, Switzerland and Netherlands, generating $153.4 million, $113.3 million and $60.7 million in revenues, respectively compared to $126.0 million, $104.3 million, and $45.8 million, respectively, in the corresponding period last year. During the nine months ended September 30, 2025, the United Kingdom, Switzerland and Germany performed as EMEA's top revenue generating locations and contributed $447.5 million, $328.2 million, and $168.4 million, respectively, compared to $389.7 million, $304.0 million, and $153.6 million, respectively, in the corresponding period last year. Revenues in the EMEA region were positively impacted by acquisitions completed in 2024, increased spending at certain large accounts and changes in foreign currency exchange rates during the three and nine months ended September 30, 2025 as compared to the same periods in the previous year.

During the three and nine months ended September 30, 2025, revenues from clients in the APAC region increased by $4.5 million or 17.7% and $8.6 million or 11.8%, respectively, mainly due to growth in the Consumer Goods, Retail & Travel vertical compared to the corresponding periods of 2024.

*Cost of Revenues (Exclusive of Depreciation and Amortization)*

The principal components of our cost of revenues (exclusive of depreciation and amortization) are salaries, bonuses, fringe benefits, stock-based compensation, project-related travel costs and fees for subcontractors who are assigned to client projects. Salaries and other compensation expenses of our delivery professionals are reported as cost of revenues regardless of whether the employees are actually performing services for clients during a given period. Our employees are a critical asset, necessary for our continued success and therefore we expect to continue hiring talented employees and providing them with competitive compensation programs. Additionally, government incentives and assistance related to services performed by delivery professionals and contractors assigned to client projects are reported in cost of revenues.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

During the three months ended September 30, 2025, cost of revenues (exclusive of depreciation and amortization) was $983.2 million representing an increase of 28.7% from $764.0 million in the corresponding period of 2024. The increase primarily resulted from the acquisitions of NEORIS and First Derivative in the fourth quarter of 2024, higher variable compensation expense, and a $38.8 million decrease in government incentives recognized in the third quarter of 2025 compared to the third quarter of 2024 related to conducting R&D activities in Poland. The third quarter of 2024 included a cumulative catch-up benefit related to Poland R&D tax credits. Expressed as a percentage of revenues, cost of revenues (exclusive of depreciation and amortization) was 70.5% and 65.4% in the third quarter of 2025 and 2024, respectively. This year-over-year increase is primarily due to the acquisitions completed in 2024, higher variable compensation expense, and a decrease in government incentives recognized in the third quarter related to conducting R&D activities in Poland.

During the nine months ended September 30, 2025, cost of revenues (exclusive of depreciation and amortization) was $2.899 billion representing an increase of 20.3% from $2.409 billion in the corresponding period of 2024. The increase primarily resulted from the acquisitions of NEORIS and First Derivative in the fourth quarter of 2024, higher variable compensation expense, and a $13.8 million decrease in government incentives recognized in the first nine months of 2025 compared to the corresponding period of 2024 related to conducting R&D activities in Poland. The first nine months of 2024 included a cumulative catch-up benefit related to Poland R&D tax credits. Expressed as a percentage of revenues, cost of revenues (exclusive of depreciation and amortization) was 71.6% and 69.3% for the nine months ended September 30, 2025 and 2024, respectively. The year-over-year increase is primarily due to the 2024 compensation increases which we were not able to fully offset through pricing increases, the acquisitions completed in 2024, higher variable compensation expense, and a decrease in government incentives recognized in the first nine months of 2025 related to conducting R&D activities in Poland.

*Selling, General and Administrative Expenses*

Selling, general and administrative expenses represent expenditures associated with promoting and selling our services and general and administrative functions of our business. These expenses include the costs of salaries, bonuses, fringe benefits, stock-based compensation, severance, bad debt, travel, legal and accounting services, insurance, facilities including operating leases, advertising, and other promotional activities. Additionally, selling, general and administrative expenses include costs of relocating our employees and various one-time and unusual expenses such as impairment charges.

During the three months ended September 30, 2025, selling, general and administrative expenses were $234.9 million representing a 13.6% increase as compared to $206.8 million in the corresponding period of 2024. The increase was mainly driven by the acquisitions of NEORIS and First Derivative completed in the fourth quarter of 2024 and higher variable compensation expense, partially offset by a decrease in professional fee expenses related to our business acquisition efforts. Expressed as a percentage of revenues, selling, general and administrative expenses decreased by 0.9% to 16.8% for the three months ended September 30, 2025 as compared to the same period from the prior year, primarily driven by a decrease in professional fee expenses related to our business acquisition efforts and a decrease in personnel-related costs, including stock-based compensation expense, as a percentage of revenues.

During the nine months ended September 30, 2025, selling, general and administrative expenses were $685.5 million representing a 14.4% increase as compared to $599.3 million in the corresponding period of 2024. The increase in selling, general and administrative expenses was mainly driven by the acquisitions of NEORIS and First Derivative completed in the fourth quarter of 2024. Expressed as a percentage of revenues, selling, general and administrative expenses decreased by 0.3% to 16.9% for the nine months ended September 30, 2025 as compared to the same period from the prior year, primarily driven by the decrease in personnel-related costs, including stock-based compensation expense, and professional fee expenses related to our business acquisition efforts as a percentage of revenues.

*Depreciation and Amortization Expense*

During the three and nine months ended September 30, 2025, depreciation and amortization expense was $31.3 million and $94.0 million, respectively, as compared to $19.7 million and $63.0 million, respectively, in the corresponding periods last year. The increase in depreciation and amortization expense during the three and nine months ended September 30, 2025 was primarily the result of increased amortization of acquired finite-lived intangible assets largely resulting from the acquisitions of First Derivative and NEORIS in 2024, partially offset by lower depreciation on furniture, fixtures, other equipment, and computer hardware. Expressed as a percentage of revenues, depreciation and amortization expense increased by 0.6% and 0.5% during the three and nine months ended September 30, 2025, respectively, primarily driven by increased amortization of acquired finite-lived intangible assets largely resulting from the acquisitions of First Derivative and NEORIS in 2024.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

*Interest and Other Income, Net*

Interest and other income, net includes interest earned on cash and cash equivalents and short-term investments, gains and losses from certain financial instruments, interest expense related to our borrowings, and changes in the fair value of contingent consideration. Interest and other income, net was $2.3 million and $11.6 million during the three and nine months ended September 30, 2025, respectively, compared to $13.3 million and $40.4 million during the three and nine months ended September 30, 2024, respectively. The decrease in Interest and other income, net during the three months ended September 30, 2025 as compared to the three months ended September 30, 2024 was largely driven by a $10.1 million decrease in interest income from our cash, cash equivalents and short-term investments. The decrease in Interest and other income, net during the nine months ended September 30, 2025 as compared to the nine months ended September 30, 2024 was largely driven by a $33.6 million decrease in interest income from our cash, cash equivalents and short-term investments, partially offset by a $4.4 million gain from the change in fair value of contingent consideration.

*Foreign Exchange Loss*

For discussion of the impact of foreign exchange fluctuations see "Item 3. Quantitative and Qualitative Disclosures About Market Risk."

*Provision for Income Taxes* 

In determining our interim provision for income taxes, we use an estimated annual effective tax rate, which is based on expected annual profit before tax, statutory tax rates and tax planning opportunities available in the various jurisdictions in which we operate. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter.

Determining the consolidated provision for income tax expense, deferred income tax assets and liabilities and any potential related valuation allowances involves judgment. We consider factors that may contribute, favorably or unfavorably, to the overall effective tax rate in the current year as well as the future. These factors include statutory tax rates and tax law changes in the countries where we operate and excess tax benefits/tax shortfalls upon vesting or exercise of stock awards as well as consideration of any significant or unusual items.

Our effective tax rate was 25.6% and 25.8% for the three and nine months ended September 30, 2025, respectively, and 28.1% and 21.4% for the three and nine months ended September 30, 2024, respectively. We recorded a tax shortfall upon vesting or exercise of stock awards of $0.2 million and $0.3 million during the three months ended September 30, 2025 and 2024, respectively. We recorded a tax shortfall upon vesting or exercise of stock awards of $0.8 million and an excess tax benefit of $20.5 million during the nine months ended September 30, 2025 and 2024, respectively. The effective tax rate during the three and nine months ended September 30, 2024 was negatively impacted by the accounting treatment of the receipt of government incentives related to conducting R&D activities in Poland, which resulted in a 2.3% and 1.0% increase in the effective tax rate, respectively, and the non-deductibility of certain acquisition costs for tax purposes which resulted in a 1.4% and 0.6% increase in the effective tax rate, respectively.

On July 4, 2025, the U.S. federal government enacted tax reform legislation, commonly referred to as the One Big Beautiful Bill Act ("the Act"), which includes a broad range of tax reform provisions. The tax law changes included in the Act did not have a material impact on the Company's effective tax rate for the three and nine months ended September 30, 2025; however, the Company expects an acceleration of certain deductions resulting in a $26.2 million reduction in cash tax payments associated with the 2025 tax year.

**Results by Business Segment**

We determine our business segments and report segment information in accordance with how the Company's chief operating decision maker ("CODM") organizes the segments to evaluate performance, allocate resources and make business decisions. Our CODM is the chief executive officer. We manage our business primarily based on the managerial responsibility for our client base and market. As managerial responsibility for a particular client relationship generally correlates with the client's geographic location, there is a high degree of similarity between client locations and the geographic boundaries of our reportable segments. In some cases, managerial responsibility for a particular client is assigned to a management team in another region and is usually based on the strength of the relationship between client executives and particular members of EPAM's senior management team. In such cases, the client's activity would be reported through the management team's reportable segment.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

Starting in 2025, we renamed our North America segment to Americas. The new name reflects the evolving geographic footprint and growth of operations within the segment, particularly in Latin America. This constitutes a naming change only and no changes were made to amounts reported.

Segment results are based on the segment's revenues and operating profit, where segment operating profit is defined as segment income from operations before unallocated costs. Expenses included in segment operating profit consist principally of direct selling and delivery costs as well as an allocation of certain shared services expenses. Intersegment transactions are excluded from the segment's revenues and operating profit on the basis that they are neither included in the measure of a segment's profit and loss results, nor considered by the CODM during the review of segment results. Certain corporate expenses are not allocated to specific segments as these expenses are not controllable at the segment level. Such expenses include certain types of professional fees, certain taxes included in operating expenses, compensation to non-employee directors and certain other general and administrative expenses, including compensation of specific groups of non-production employees. In addition, we do not allocate amortization of intangible assets acquired through business combinations, goodwill and other asset impairment charges, stock-based compensation expenses, acquisition-related costs and certain other one-time charges and benefits. These unallocated amounts are combined with total segment operating profit to arrive at consolidated income from operations.

Our CODM considers the operating results of each segment on a quarterly basis and uses segment operating profit predominantly to assess the performance of each segment by comparing the results of each segment with one another and to historical performance. When combined with certain other financial information, this enables the CODM to make decisions about the reporting structure, allocation of operating and capital resources, and compensation of certain employees.

During the year ended December 31, 2024, the Company revised its CODM report to enhance the presentation of segment expenses by category and to revise the allocation methodology for certain types of shared expenses. The following prior period amounts presented have been revised to align with the current methodology. No changes were made to historically reported segment revenues.

See Note 16 "Segment Information" in the notes to our condensed consolidated interim financial statements in this Form 10-Q for more information related to our reportable segments.

*Americas Segment*

The following table summarizes revenues from external clients and operating profit, before unallocated expenses, for the Americas segment for the three and nine months ended September 30, 2025, and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Americas segment revenues** | $**799869** | $**704613** | $**2364437** | $**2107971** |
| Less: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues (exclusive of depreciation and amortization) | 548161 | 447952 | 1643778 | 1410358 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 106753 | 90819 | 312270 | 269102 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 8656 | 9120 | 27372 | 29578 |
| **Americas segment operating profit** | $**136299** | $**156722** | $**381017** | $**398933** |

---

During the three months ended September 30, 2025, revenues for the Americas segment increased $95.3 million, or 13.5%, compared to the same period last year and segment operating profit decreased $20.4 million, or 13.0%, compared to the same period last year. Acquisitions contributed $66.3 million to Americas segment revenues during the three months ended September 30, 2025. During the three months ended September 30, 2025, revenues from our Americas segment were 57.4% of total segment revenues, a decrease from 60.4% reported in the corresponding period of 2024. As a percentage of Americas segment revenues, the Americas segment's operating profit decreased to 17.0% during the third quarter of 2025 from 22.2% in the third quarter of 2024. This decrease is primarily attributable to lower government incentives related to conducting R&D activities in Poland, the impact of lower profitability from acquisitions completed in 2024, and an increase in variable compensation expense as a percentage of segment revenues during the third quarter of 2025 compared to the third quarter of 2024.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

During the nine months ended September 30, 2025, revenues for the Americas segment increased $256.5 million, or 12.2%, compared to the same period last year and segment operating profit decreased $17.9 million, or 4.5%, compared to the same period last year. Acquisitions contributed $211.4 million to Americas segment revenues during the nine months ended September 30, 2025. During the nine months ended September 30, 2025, revenues from our Americas segment were 58.4% of total segment revenues, a decrease from 60.6% reported in the corresponding period of 2024. As a percentage of Americas segment revenues, the Americas segment's operating profit decreased to 16.1% during the nine months ended September 30, 2025 from 18.9% in the nine months ended September 30, 2024. This decrease is primarily attributable to lower government incentives related to conducting R&D activities in Poland, the impact of lower profitability from acquisitions completed in 2024, changes in foreign exchange rates, and an increase in variable compensation expense as a percentage of segment revenues during the first nine months of 2025 compared to the first nine months of 2024.

The following table presents Americas segment revenues by industry vertical for the periods indicated:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Change** | **Change** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Change** | **Change** |
| | **2025** | **2024** | **Dollars** | **Percentage** | **2025** | **2024** | **Dollars** | **Percentage** |
| **<u>Industry Vertical</u>** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** |
| Financial Services | $150573 | $129339 | $21234 | 16.4% | $448475 | $377000 | $71475 | 19.0% |
| Software & Hi-Tech | 143191 | 131145 | 12046 | 9.2% | 423163 | 392600 | 30563 | 7.8% |
| Life Sciences & Healthcare | 124943 | 120659 | 4284 | 3.6% | 375859 | 362983 | 12876 | 3.5% |
| Consumer Goods, Retail & Travel | 122673 | 107866 | 14807 | 13.7% | 356090 | 339556 | 16534 | 4.9% |
| Business Information & Media | 116848 | 115121 | 1727 | 1.5% | 348912 | 332602 | 16310 | 4.9% |
| Emerging Verticals | 141641 | 100483 | 41158 | 41.0% | 411938 | 303230 | 108708 | 35.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**799869** | $**704613** | $**95256** | **13.5%** | $**2364437** | $**2107971** | $**256466** | **12.2%** |

---

During the three and nine months ended September 30, 2025, Financial Services was the largest industry vertical in the Americas segment and grew 16.4% and 19.0%, respectively, compared to the corresponding periods of 2024, benefiting from new revenues from clients gained through our 2024 acquisitions. Software & Hi-Tech grew 9.2% and 7.8% during the three and nine months ended September 30, 2025, respectively, which was a result of the continued focus on engaging with our technology clients. Life Sciences & Healthcare grew 3.6% and 3.5% during the three and nine months ended September 30, 2025, respectively, primarily due to increased demand from pharmaceutical, medical device and healthcare companies. Consumer Goods, Retail & Travel grew 13.7% and 4.9% during the three and nine months ended September 30, 2025, respectively, primarily due to growth from our retail clients. Business Information & Media grew 1.5% and 4.9% during the three and nine months ended September 30, 2025, respectively, primarily due to improvement in demand from clients in the publishing and entertainment sectors. Emerging Verticals grew 41.0% and 35.9% during the three and nine months ended September 30, 2025, respectively, primarily due to revenues from clients gained through our 2024 acquisitions as well as growth from various clients in industries such as energy and industrial materials.

*Europe Segment*

The following table summarizes revenues from external clients and operating profit, before unallocated expenses, for the Europe segment for the three and nine months ended September 30, 2025, and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Europe segment revenues** | $**594504** | $**462914** | $**1685071** | $**1371618** |
| Less: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of revenues (exclusive of depreciation and amortization) | 421398 | 300572 | 1200316 | 952551 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 79767 | 65543 | 230811 | 198110 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 4438 | 4909 | 12940 | 15949 |
| **Europe segment operating profit** | $**88901** | $**91890** | $**241004** | $**205008** |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

During the three months ended September 30, 2025, Europe's segment revenues were $594.5 million, representing an increase of $131.6 million, or 28.4%, from the same period last year. Acquisitions completed in the prior 12 months contributed $55.8 million to Europe segment revenues during the three months ended September 30, 2025. Revenues were positively impacted by changes in foreign currency exchange rates during the third quarter of 2025 and had our Europe segment revenues been expressed in constant currency terms using the exchange rates in effect during the third quarter of 2024, we would have reported revenue growth of 23.8%. Europe's segment revenues accounted for 42.6% and 39.6% of total segment revenues during the three months ended September 30, 2025 and 2024, respectively. During the third quarter of 2025, the segment's operating profit decreased 3.3% to $88.9 million compared to the third quarter of 2024. Expressed as a percentage of revenues, Europe's segment operating profit decreased to 15.0% compared to 19.9% in the same period of the prior year. Segment operating profit as a percentage of revenues was negatively impacted by lower government incentives related to conducting R&D activities in Poland and an increase in variable compensation expense as a percentage of segment revenues, partially offset by changes in foreign exchange rates and results of Cost Optimization Programs during the third quarter of 2025 compared to the third quarter of 2024.

During the nine months ended September 30, 2025, Europe's segment revenues were $1.685 billion, representing an increase of $313.5 million, or 22.9%, from the same period last year. Acquisitions completed in the prior 12 months contributed $164.8 million to Europe segment revenues during the nine months ended September 30, 2025. Europe's segment revenues accounted for 41.6% and 39.4% of total segment revenues during the nine months ended September 30, 2025 and 2024, respectively. During the nine months ended September 30, 2025, the segment's operating profit increased 17.6% to $241.0 million compared to the corresponding period of 2024. Expressed as a percentage of revenues, Europe's segment operating profit decreased to 14.3% compared to 14.9% in the same period of the prior year. Segment operating profit as a percentage of revenues was negatively impacted by lower government incentives related to conducting R&D activities in Poland and an increase in variable compensation expense as a percentage of segment revenues, partially offset by changes in foreign exchange rates and results of Cost Optimization Programs during the first nine months of 2025 compared to the first nine months of 2024.

The following table presents Europe segment revenues by industry vertical for the periods indicated:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Change** | **Change** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Change** | **Change** |
| | **2025** | **2024** | **Dollars** | **Percentage** | **2025** | **2024** | **Dollars** | **Percentage** |
| **<u>Industry Vertical</u>** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** | **(in thousands, except percentages)** |
| Financial Services | $187228 | $125296 | $61932 | 49.4% | $531604 | $364740 | $166864 | 45.7% |
| Consumer Goods, Retail & Travel | 153354 | 143259 | 10095 | 7.0% | 443499 | 423026 | 20473 | 4.8% |
| Software & Hi-Tech | 68965 | 46928 | 22037 | 47.0% | 183737 | 127727 | 56010 | 43.9% |
| Business Information & Media | 50782 | 52273 | (1491) | (2.9)% | 155658 | 170872 | (15214) | (8.9)% |
| Life Sciences & Healthcare | 34251 | 21675 | 12576 | 58.0% | 94794 | 59644 | 35150 | 58.9% |
| Emerging Verticals | 99924 | 73483 | 26441 | 36.0% | 275779 | 225609 | 50170 | 22.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Revenues** | $**594504** | $**462914** | $**131590** | **28.4%** | $**1685071** | $**1371618** | $**313453** | **22.9%** |

---

During the three and nine months ended September 30, 2025, Financial Services was the largest industry vertical in the Europe segment and grew 49.4% and 45.7%, respectively, compared to the corresponding periods of 2024, benefiting from new revenues from clients that we gained as part of our 2024 acquisitions. During the three and nine months ended September 30, 2025, revenues in Consumer Goods, Retail & Travel grew 7.0% and 4.8%, respectively, primarily due to improved demand from clients in the retail and consumer goods industries. During the three and nine months ended September 30, 2025, revenues in Software & Hi-Tech grew 47.0% and 43.9%, respectively, primarily due to the expansion of services provided to one of our top 10 clients as well as the addition of several new clients in the past 12 months. During the three and nine months ended September 30, 2025, revenues in Business Information & Media declined 2.9% and 8.9%, respectively, primarily due to decreased demand from two clients who were historically included in our top 10 clients. Revenues in Life Sciences & Healthcare grew 58.0% and 58.9%, respectively, during the three and nine months ended September 30, 2025, primarily due to the growth experienced from clients in the pharmaceutical and medical devices sectors. Revenues in Emerging Verticals grew 36.0% and 22.2%, respectively, during the three and nine months ended September 30, 2025, due to growth from various clients in industries such as energy, professional services and industrial materials. Emerging Verticals also benefited from new revenues from clients gained through our 2024 acquisitions.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**Effects of Inflation**

Economies in many countries where we operate have periodically experienced high rates of inflation. Periods of higher inflation may affect various economic sectors in those countries and increase our cost of doing business there. We do not believe that inflation has had a material impact on our business, results of operations or financial condition to date. We continue to track the impact of inflation, particularly on wages, while attempting to minimize its effects through pricing and cost management strategies. A higher-than-normal rate of inflation in the future could adversely affect our operations and financial condition. For a discussion of our potential risks and uncertainties, including those related to inflation, see "Part I. Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Liquidity and Capital Resources**

***Capital Resources***

Our cash generated from operations has been our primary source of liquidity to fund operations, to repurchase shares and make investments to support the growth of our business. As of September 30, 2025, our principal sources of liquidity were cash and cash equivalents totaling $1.239 billion, short-term investments totaling $5.2 million, and $675.0 million of available borrowings under our revolving credit facility. See Note 8 "Debt" of our condensed consolidated financial statements in "Part I. Item 1. Financial Statements (Unaudited)" for information regarding our debt.

***Cash Flows***

The following table summarizes our cash flows for the periods indicated:

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| | **(in thousands)** | **(in thousands)** |
| **Condensed Consolidated Statements of Cash Flow Data:** |  |  |
| Net cash provided by operating activities | $372044 | $428909 |
| Net cash used in investing activities | (32802) | (39100) |
| Net cash used in financing activities | (439219) | (391667) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 53100 | (543) |
| Net decrease in cash, cash equivalents and restricted cash | (46877) | (2401) |
| Cash, cash equivalents and restricted cash, beginning of period | 1290392 | 2043108 |
| Cash, cash equivalents and restricted cash, end of period | $1243515 | $2040707 |

---

*Operating Activities*

Our largest source of cash provided by operating activities is cash generated from our professional services that we provide to our clients. Our primary uses of cash from operating activities include compensation to our employees and related costs, payments for leased facilities, various general corporate expenditures and income tax payments. Since the invasion of Ukraine in 2022, our operating activities included using cash on humanitarian efforts for Ukraine and geographic repositioning of our workforce. The first nine months of 2025 were negatively impacted by a larger increase in days sales outstanding compared to the first nine months of 2024 and higher payments for variable compensation as compared to the first nine months of 2024, attributable to a higher level of financial performance for the year ended December 31, 2024.

*Investing Activities*

Our primary uses of cash in investing activities consist of purchases of computer hardware, software and office equipment, as well as investments into office buildings and new businesses. We also use cash for short-term investments and time deposits and receive cash upon maturity of these deposits. Most of our investments are typically short-term and cash equivalent in nature but we may invest in longer term deposits if the terms are favorable. The cash used in investing activities during the nine months ended September 30, 2025 was primarily attributable to $27.5 million used for capital expenditures compared to $16.4 million used for capital expenditures in the corresponding period of 2024. During the nine months ended September 30, 2025, $3.3 million was used for the acquisitions of businesses, net of cash acquired compared to $57.1 million used for the acquisitions of businesses, net of cash acquired in the corresponding period of 2024. There were no proceeds from short-term investments during the nine months ended September 30, 2025 compared to $41.5 million in the corresponding period of 2024.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

*Financing Activities*

Cash used in financing activities mainly consists of repurchasing shares of EPAM common stock under our share repurchase programs, payments of withholding taxes related to net share settlements of restricted stock units, repayments of debt, and settlements of the acquisition-date fair value of contingent consideration related to acquisitions of businesses. Cash provided by financing activities mainly consists of the proceeds from the purchases of shares under our ESPP and exercises of stock options issued under our long-term incentive plans as well as proceeds from debt. We typically do not rely on debt to supplement our cash flows. During the first nine months of 2025, our main use of cash in financing activities consisted of $438.6 million of payments to repurchase our common stock, compared to $385.0 million in the corresponding period of 2024. These cash outflows were partially offset by cash received from the exercises of stock options issued under our long-term incentive plans and proceeds from the purchase of shares under our ESPP of $35.0 million in the first nine months of 2025, compared to $33.8 million received in the corresponding period of 2024.

**Future Capital Requirements**

We believe that our existing cash, cash equivalents and short-term investments, combined with our expected cash flow from operations will be sufficient to meet our projected operating and capital expenditure requirements for at least the next twelve months and that we possess the financial flexibility to execute our strategic objectives, including the ability to make acquisitions and strategic investments in the foreseeable future. However, the invasion of Ukraine, other various geopolitical events, and the related measures implemented to contain their impact, have caused and may continue to cause material disruptions in financial markets and economies. These disruptions may increase our costs of capital, decrease returns on investment, and otherwise adversely affect our business, results of operations, financial condition and liquidity.

Our ability to generate cash is subject to our performance, general economic conditions, industry trends and other factors including the impact of the invasion of Ukraine, as described elsewhere in this Management's Discussion and Analysis of Financial Condition and Results of Operations. We may require additional cash resources due to changed business conditions or other future developments, including any investments or acquisitions we may decide to pursue. To the extent that existing cash, cash equivalents, short-term investments, and operating cash flows are insufficient to fund our future activities and requirements, we may need to raise additional funds through public or private equity or debt financing. If we issue equity securities in order to raise additional funds, substantial dilution to existing stockholders may occur. If we raise cash through the issuance of additional indebtedness, we may be subject to additional contractual restrictions on our business and there is no assurance that we would be able to raise additional funds on favorable terms or at all. Our ability to expand and grow our business in accordance with current plans and to meet our long-term capital requirements will depend on many factors, including the rate at which our cash flows increase or decrease and the availability of public and private debt and equity financing.

See Note 15 "Commitments and Contingencies" of our condensed consolidated financial statements in "Part I. Item 1. Financial Statements (Unaudited)" of this Quarterly Report and "Part II. Item 7. Future Capital Requirements" of our Annual Report on Form 10-K for the year ended December 31, 2024 for information regarding contractual obligations.

**Off-Balance Sheet Commitments and Arrangements**

We do not have any material obligations under guarantee contracts or other contractual arrangements other than as disclosed in Note 15 "Commitments and Contingencies" of our condensed consolidated financial statements in "Part I. Item 1. Financial Statements (Unaudited)." We have not entered into any transactions with unconsolidated entities where we have financial guarantees, subordinated retained interests, derivative instruments, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk, or credit risk support to us, or engages in leasing, hedging, or research and development services with us.

**Recent Accounting Pronouncements**

See Note 1 "Organization and Summary of Significant Accounting Policies" to our unaudited condensed consolidated financial statements in "Part I. Item 1. Financial Statements (Unaudited)" for additional information.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**Forward-Looking Statements**

This quarterly report on Form 10-Q contains estimates and forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, principally in "Part I. Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Part II. Item 1A. Risk Factors." Our Annual Report on Form 10-K for the year ended December 31, 2024 also contains estimates and forward-looking statements, principally in "Part I. Item 1A. Risk Factors." Our estimates and forward-looking statements are based on our current expectations and estimates of future events and trends, which affect or may affect our businesses and operations. Those future events and trends may relate to, among other things, developments relating to the war in Ukraine and escalation of the war in the surrounding region, political and civil unrest or military action in the geographies where we conduct business and operate, difficult conditions in global capital markets, foreign exchange markets, global trade and the broader economy, the adoption and implementation of artificial intelligence technologies by EPAM and its clients, and the effect that these events may have on client demand, our revenues, operations, access to capital and profitability. Although we believe that these estimates and forward-looking statements are based upon reasonable assumptions, they are subject to several risks, uncertainties and assumptions as to future events that may not prove to be accurate and are made in light of information currently available to us. Important factors, in addition to the factors described in this quarterly report and in our Annual report, may materially and adversely affect our results. You should read this quarterly report, our Annual report and the documents that we have filed as exhibits hereto completely and with the understanding that our actual future results may be materially different from what we expect.

The words "may," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "intend," "potential," "might," "would," "continue" or the negative of these terms or other comparable terminology and similar words are intended to identify estimates and forward-looking statements. Estimates and forward-looking statements speak only as of the date they were made and, except to the extent required by law, we undertake no obligation to update, to correct, to revise or to review any estimate and/or forward-looking statement because of new information, future events or other factors. Estimates and forward-looking statements involve risks and uncertainties and are not guarantees of future performance. As a result of the risks and uncertainties described above, the estimates and forward-looking statements discussed in this quarterly report and our Annual Report on Form 10-K for the year ended December 31, 2024 might not occur and our future results, level of activity, performance or achievements may differ materially from those expressed in these forward-looking statements due to, including, but not limited to, the factors mentioned above, and the differences may be material and adverse. Because of these uncertainties, you should not place undue reliance on these forward-looking statements.

***Item 3. Quantitative and Qualitative Disclosures About Market Risk***

We are exposed to certain market risks in the ordinary course of our business. These risks primarily result from changes in concentration of credit risks, foreign currency exchange rates and interest rates. In addition, our global operations are subject to risks related to differing economic conditions, global trade, civil unrest, political instability or uncertainty, military activities, broad-based sanctions, differing tax structures, and other changing regulations and restrictions.

**Concentration of Credit and Other Credit Risks**

Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, short-term investments and trade receivables.

We maintain our cash, cash equivalents and short-term investments with financial institutions. We believe that our credit policies reflect normal industry terms and business risk. We do not anticipate non-performance by the counterparties.

We have cash in several countries, including Ukraine and Belarus, where the banking sector remains subject to periodic instability; banking and other financial systems in these countries generally do not meet the banking standards of more developed markets, and bank deposits made by corporate entities are not insured. As of September 30, 2025, we had $44.7 million of cash and cash equivalents in banks in Ukraine and $24.6 million of cash and cash equivalents in banks in Belarus. We regularly monitor cash held in these countries and, to the extent the cash held exceeds the amounts required to support our operations in these countries, we distribute the excess funds into markets with more developed banking sectors to the extent it is possible to do so. In April 2024, Belarus instituted restrictions on distributing dividends from Belarus to shareholders in certain countries, including the U.S. The restrictions are scheduled to remain in place until the end of 2026 and may prevent EPAM from distributing excess funds, if any, out of Belarus. We do not expect these restrictions to have a material impact on our ability to meet our worldwide cash obligations during this period. We place our cash and cash equivalents with financial institutions considered stable in the region, limit the amount of credit exposure with any one financial institution and conduct ongoing evaluations of the credit worthiness of the financial institutions with which we do business. However, a banking crisis, bankruptcy or insolvency of banks that process or hold our funds, or sanctions may result in the loss of our deposits or adversely affect our ability to complete banking transactions, which could adversely affect our business and financial condition.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

Trade receivables are generally dispersed across many clients operating in different industries and geographies; therefore, concentration of credit risk is limited and we do not believe significant credit risk existed as of September 30, 2025. Though our results of operations depend on our ability to successfully collect payment from our clients for work performed, historically, credit losses and write-offs of trade receivables have not been material to our condensed consolidated financial statements. If our clients enter bankruptcy protection or otherwise take steps to alleviate their financial distress, our credit losses and write-offs of trade receivables could increase, which would negatively impact our results of operations.

**Interest Rate Risk**

We are exposed to market risk from changes in interest rates. Exposure to interest rate risk results primarily from variable rates related to cash and cash equivalent deposits, short-term investments, and our borrowings, mainly under our 2021 Credit Agreement (and 2025 Credit Agreement subsequent to October 3, 2025), which is subject to a variety of rates depending on the currency and timing of funds borrowed. We do not believe we are exposed to material direct risks associated with changes in interest rates related to these deposits, investments and borrowings.

**Foreign Exchange Risk** 

Our global operations are conducted predominantly in U.S. dollars. Other than U.S. dollars, we generate revenues principally in euros, British pounds, Swiss francs, Mexican pesos and Canadian dollars and incur expenditures principally in euros, Polish zlotys, Indian rupees, British pounds, Mexican pesos, Colombian pesos, Hungarian forints, Swiss francs and Canadian dollars. As a result, exchange rate fluctuations in any of these currencies relative to the U.S. dollar could negatively impact our results of operations. During the three months ended September 30, 2025, approximately 39.9% of consolidated revenues and 61.4% of consolidated operating expenses were denominated in currencies other than the U.S. dollar.

To manage the risk of fluctuations in foreign currency exchange rates and hedge a portion of our forecasted foreign currency denominated operating expenses incurred in the normal course of business, we implemented a hedging program through which we enter into a series of foreign exchange forward contracts with durations of twelve months or less that are designated as cash flow hedges of forecasted Polish zloty, Indian rupee, Hungarian forint and Mexican peso transactions. As of September 30, 2025, all of EPAM's foreign exchange forward contracts were designated as hedges and there is no financial collateral (including cash collateral) required to be posted related to the foreign exchange forward contracts.

During the three months ended September 30, 2025, foreign exchange loss was $3.6 million compared to a loss of $0.7 million reported in the corresponding period last year. Foreign exchange loss was primarily driven by the impact of fluctuations in foreign currencies on our assets and liabilities denominated in foreign currencies. Exchange rate movements can impact the reported value of our assets and liabilities denominated in currencies other than the U.S. dollar or where the currency of such items is different than the functional currency of the entity where these items were recorded.

Management supplements results reported in accordance with United States generally accepted accounting principles, referred to as GAAP, with non-GAAP financial measures. Management believes these measures help illustrate underlying trends in our business and uses the measures to establish budgets and operational goals, communicated internally and externally, for managing our business and evaluating our performance. When important to management's analysis, operating results are compared on the basis of "constant currency," which is a non-GAAP financial measure. This measure excludes the effect of foreign currency exchange rate fluctuations by translating the current period revenues and expenses into U.S. dollars at the weighted average exchange rates of the prior period of comparison.

During the third quarter of 2025, we reported revenue growth of 19.4% compared to the third quarter of 2024. Had our consolidated revenues been expressed in constant currency terms using the exchange rates in effect during the third quarter of 2024, we would have reported revenue growth of 17.4%. Our revenues denominated in euros, British pounds and Swiss francs experienced the most impact from the movements in foreign currencies. During the third quarter of 2025, we reported a decrease in income from operations of 18.1% compared to the third quarter of 2024. Had our consolidated results been expressed in constant currency terms using the exchange rates in effect during the third quarter of 2024, we would have reported a decrease in income from operations of 19.8%. Income from operations was most significantly impacted by the movements of the euro, Indian rupee, British pound, Polish zloty, Swiss franc and Hungarian forint exchange rates during the third quarter of 2025 compared to the same period in the prior year.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

***Item 4. Controls and Procedures***

**Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures**

Based on management's evaluation, with the participation of our Chief Executive Officer and Chief Financial Officer, as of the end of the period covered by this report, these officers have concluded that our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are effective to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

**Changes in Internal Control Over Financial Reporting**

There has been no change in our internal control over financial reporting during the quarter ended September 30, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION**

***Item 1. Legal Proceedings***

From time to time, we are involved in litigation and claims arising out of our business and operations in the normal course of business. We are not currently a party to any material legal proceeding, nor are we aware of any material legal or governmental proceedings pending or contemplated to be brought against us.

***Item 1A. Risk Factors***

For a discussion of our potential risks and uncertainties, including our significant operations in Belarus and Ukraine and the material adverse effect the invasion of Ukraine by Russia has had and may have on our operations, business, and financial results, see the risk factors disclosed under the heading "Part I. Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024.

The risks and uncertainties that we face are not limited to those set forth in our Annual Report on Form 10-K. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business and the trading price of our common stock.

***Item 2. Unregistered Sales of Equity Securities and Use of Proceeds***

**Issuer Purchases of Equity Securities**

On August 1, 2024, the Board of Directors authorized a share repurchase program (the "2024 Repurchase Program") for up to $500.0 million of our outstanding common stock. EPAM could repurchase shares of its common stock on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. As of September 30, 2025, the Company exhausted the $500.0 million available for purchases of the Company's common stock under the 2024 Repurchase Program.

On October 16, 2025, the Board of Directors authorized a new share repurchase program (the "2025 Repurchase Program") for up to $1,000.0 million of the Company's outstanding common stock. See Note 12 "Stockholders' Equity" in the notes to our condensed consolidated interim financial statements in this Form 10-Q for more information related to the new program.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

The following table provides information about the purchases of shares of our common stock during the three months ended September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of<br>Shares Purchased** | **Average Price Paid**<br>**per Share** <sup>(1)</sup> | **Total Number of<br>Shares Purchased as<br>Part of Publicly<br>Announced Plans or<br>Programs** | **Approximate Dollar<br>Value of Shares that<br>May Yet Be Purchased<br>Under the Plans or<br>Programs** |
| | **(in thousands, except per share amounts)** | **(in thousands, except per share amounts)** | **(in thousands, except per share amounts)** | **(in thousands, except per share amounts)** |
| July 1 to July 31, 2025 |  | $— |  | $82104 |
| August 1 to August 31, 2025 | 301 | $166.32 | 301 | $31961 |
| September 1 to September 30, 2025 | 192 | $166.81 | 192 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total** | **493** |  | **493** |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Average price paid per share in the period includes commission and excludes excise tax. As of January 1, 2023, our share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. Any excise tax incurred is recognized as part of the cost basis of the shares acquired in the condensed consolidated statements of changes in equity.

***Item 3. Defaults Upon Senior Securities***

None.

***Item 4. Mine Safety Disclosures***

Not Applicable.

***Item 5. Other Information***

**Insider Adoption or Termination of Trading Arrangements:**

On August 13, 2025, Balazs Fejes, Chief Executive Officer and President, terminated a trading arrangement for the sale of securities of the Company's common stock that was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) (a "Rule 10b5-1 Trading Plan") that was entered into on March 7, 2025. On August 19, 2025, Mr. Fejes entered into a Rule 10b5-1 Trading Plan that expires on August 15, 2026 and provides for the sale of up to 18,819 shares of common stock underlying stock options according to the terms of his Rule 10b5-1 Trading Plan.

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

***Item 6. Exhibits***

---

| | |
|:---|:---|
| **Exhibit<br>Number** | **Description** |
| 31.1\* | <u>[Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934](exhibit311q32025.htm)</u> |
| 31.2\* | <u>[Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934](exhibit312q32025.htm)</u> |
| 32.1\* | <u>[Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](exhibit321q32025.htm)</u> |
| 32.2\* | <u>[Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](exhibit322q32025.htm)</u> |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File - (formatted as Inline XBRL and contained in Exhibit 101) |
| \* | Exhibits filed herewith |

---

------

**<u>[Table of contents](#i77da24089f294b0e9bff2a6a11637bd1_7)</u>**

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 6, 2025

---

| | |
|:---|:---|
| EPAM SYSTEMS, INC. | EPAM SYSTEMS, INC. |
| By: | /s/ Balazs Fejes |
|  | Name: Balazs Fejes |
|  | Title: Chief Executive Officer and President<br>(principal executive officer) |
| By: | /s/ Jason Peterson |
|  | Name: Jason Peterson |
|  | Title: Senior Vice President, Chief Financial Officer and Treasurer <br>(principal financial officer) |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**Certification by Chief Executive Officer**

**Pursuant to Securities Exchange Act Rule 13a-14(a)**

I, Balazs Fejes, certify that:

1. I have reviewed this quarterly report on Form 10-Q of EPAM Systems, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 6, 2025

---

| |
|:---|
| /s/ Balazs Fejes |
| Balazs Fejes |
| Chief Executive Officer and President <br>(principal executive officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**Certification by Chief Financial Officer**

**Pursuant to Securities Exchange Act Rule 13a-14(a)**

I, Jason Peterson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of EPAM Systems, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 6, 2025

---

| |
|:---|
| /s/ Jason Peterson |
| Jason Peterson |
| Senior Vice President, Chief Financial Officer and Treasurer<br>(principal financial officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of EPAM Systems, Inc. (the "Company") for the quarter ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Balazs Fejes, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 6, 2025

---

| |
|:---|
| /s/ Balazs Fejes |
| Balazs Fejes |
| Chief Executive Officer and President <br>(principal executive officer) |

---

## Exhibit 32.2

**EXHIBIT 32.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of EPAM Systems, Inc. (the "Company") for the quarter ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Jason Peterson, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 6, 2025

---

| |
|:---|
| /s/ Jason Peterson |
| Jason Peterson |
| Senior Vice President, Chief Financial Officer and Treasurer<br>(principal financial officer) |

---

<br>